Raras
Buscar doenças, sintomas, genes...
Disostose
ORPHA:364559DOENÇA RARA

Um grupo de doenças onde o problema principal está nos ossos, se manifestando como alterações em ossos específicos ou em um grupo deles.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um grupo de doenças onde o problema principal está nos ossos, se manifestando como alterações em ossos específicos ou em um grupo deles.

Pesquisas ativas
3 ensaios
146 total registrados no ClinicalTrials.gov
Publicações científicas
2.679 artigos
Último publicado: 1993
Medicamentos
7 registrados
EPOPROSTENOL, PRAVASTATIN, IRBESARTAN

Tem tratamento?

7 medicamentos registrados
Ver detalhes, fases e interações →
EPOPROSTENOLPRAVASTATINIRBESARTANAMINOCAPROIC ACIDVALPROIC ACIDRITUXIMABVALPROATE SODIUM
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
382 sintomas
😀
Face
141 sintomas
👁️
Olhos
81 sintomas
❤️
Coração
79 sintomas
🧠
Neurológico
77 sintomas
🧬
Pele e cabelo
72 sintomas

+ 866 sintomas em outras categorias

Características mais comuns

Testa inclinada
Volume expiratório forçado em um segundo reduzido
Displasia ungueal
Hipertrofia biventricular
Ausência parcial do pé
Fístula urogenital
2056sintomas
Sem dados (2056)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 2056 características clínicas mais associadas, ordenadas por frequência.

Testa inclinadaSloping forehead
Volume expiratório forçado em um segundo reduzidoReduced forced expiratory volume in one second
Displasia unguealFingernail dysplasia
Hipertrofia biventricularBiventricular hypertrophy
Ausência parcial do péPartial absence of foot

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.679PubMed
Últimos 10 anos200publicações
Pico202573 papers
Linha do tempo
2026Hoje · 2026🧪 1994Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

68 genes identificados com associação a esta condição.

IL11RAInterleukin-11 receptor subunit alphaCandidate gene tested inTolerante
FUNÇÃO

Receptor for interleukin-11 (IL11). The receptor systems for IL6, LIF, OSM, CNTF, IL11 and CT1 can utilize IL6ST for initiating signal transmission. The IL11/IL11RA/IL6ST complex may be involved in the control of proliferation and/or differentiation of skeletogenic progenitor or other mesenchymal cells (Probable). Essential for the normal development of craniofacial bones and teeth. Restricts suture fusion and tooth number Soluble form of IL11 receptor (sIL11RA) that acts as an agonist of IL11 a

LOCALIZAÇÃO

MembraneSecreted

VIAS BIOLÓGICAS (1)
IL-6-type cytokine receptor ligand interactions
MECANISMO DE DOENÇA

Craniosynostosis and dental anomalies

A disorder characterized by craniosynostosis, maxillary hypoplasia, and dental anomalies, including malocclusion, delayed and ectopic tooth eruption, and/or supernumerary teeth. Some patients also display minor digit anomalies, such as syndactyly and/or clinodactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
80.6 TPM
Cervix Ectocervix
74.6 TPM
Tireoide
67.1 TPM
Cólon sigmoide
64.2 TPM
Útero
62.3 TPM
OUTRAS DOENÇAS (1)
craniosynostosis and dental anomalies
HGNC:5967UniProt:Q14626
POLR1DDNA-directed RNA polymerases I and III subunit RPAC2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I and III which synthesize ribosomal RNA precursors and short non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs, respectively

LOCALIZAÇÃO

NucleusNucleus, nucleolus

VIAS BIOLÓGICAS (1)
Cytosolic sensors of pathogen-associated DNA
MECANISMO DE DOENÇA

Treacher Collins syndrome 2

A form of Treacher Collins syndrome, a disorder of craniofacial development. Treacher Collins syndrome is characterized by a combination of bilateral downward slanting of the palpebral fissures, colobomas of the lower eyelids with a paucity of eyelashes medial to the defect, hypoplasia of the facial bones, cleft palate, malformation of the external ears, atresia of the external auditory canals, and bilateral conductive hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
33.5 TPM
Testículo
33.4 TPM
Cérebro - Hemisfério cerebelar
27.6 TPM
Cervix Ectocervix
26.9 TPM
Skin Not Sun Exposed Suprapubic
26.1 TPM
OUTRAS DOENÇAS (2)
Treacher Collins syndrome 2Treacher-Collins syndrome
HGNC:20422UniProt:P0DPB6
TCOF1Treacle proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:12777385, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with NOLC1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating

LOCALIZAÇÃO

Nucleus, nucleolus

MECANISMO DE DOENÇA

Treacher Collins syndrome 1

A form of Treacher Collins syndrome, a disorder of craniofacial development. Treacher Collins syndrome is characterized by a combination of bilateral downward slanting of the palpebral fissures, colobomas of the lower eyelids with a paucity of eyelashes medial to the defect, hypoplasia of the facial bones, cleft palate, malformation of the external ears, atresia of the external auditory canals, and bilateral conductive hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
46.7 TPM
Fibroblastos
37.3 TPM
Útero
35.9 TPM
Cólon sigmoide
32.1 TPM
Cervix Ectocervix
31.0 TPM
OUTRAS DOENÇAS (2)
Treacher Collins syndrome 1Treacher-Collins syndrome
HGNC:11654UniProt:Q13428
BTRCF-box/WD repeat-containing protein 1ACandidate gene tested inTolerante
FUNÇÃO

Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:10066435, PubMed:10497169, PubMed:10644755, PubMed:10835356, PubMed:11158290, PubMed:11238952, PubMed:11359933, PubMed:11994270, PubMed:12791267, PubMed:12902344, PubMed:14603323, PubMed:14681206, PubMed:14988407, PubMed:15448698, PubMed:15917222, PubMed:16371461, PubMed:22017875, PubMed:22017876

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
SCF-beta-TrCP mediated degradation of Emi1MAP3K8 (TPL2)-dependent MAPK1/3 activationRegulation of PLK1 Activity at G2/M TransitionActivation of NF-kappaB in B cellsAntigen processing: Ubiquitination & Proteasome degradation
OUTRAS DOENÇAS (1)
split hand-foot malformation
HGNC:1144UniProt:Q9Y297
RSPO2R-spondin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Activator of the canonical Wnt signaling pathway by acting as a ligand for LGR4-6 receptors. Upon binding to LGR4-6 (LGR4, LGR5 or LGR6), LGR4-6 associate with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. Also regulates the canonical Wnt/beta-catenin-dependent pathway and non-canonical Wnt signaling by acting as an inhibitor of ZNRF3, an important regulator of t

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Regulation of FZD by ubiquitination
MECANISMO DE DOENÇA

Tetraamelia syndrome 2

A form of tetraamelia, a rare disease characterized by rudimentary appendages or complete absence of all four limbs, and other anomalies such as craniofacial, nervous system, pulmonary, skeletal and urogenital defects. TETAMS2 patients manifest limb deformities, bilateral agenesis of the lungs, abnormalities of the pulmonary vasculature, labioscrotal fold aplasia, and dysmorphic features including bilateral cleft lip/palate, ankyloglossia, mandibular hypoplasia, and microretrognathia. TETAMS2 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
13.8 TPM
Cólon sigmoide
11.5 TPM
Córtex cerebral
8.8 TPM
Esôfago - Junção
6.5 TPM
Pulmão
5.4 TPM
OUTRAS DOENÇAS (3)
tetraamelia syndrome 2humerofemoral hypoplasia with radiotibial ray deficiencytetraamelia-multiple malformations syndrome
HGNC:28583UniProt:Q6UXX9
FBXW4F-box/WD repeat-containing protein 4Candidate gene tested inTolerante
FUNÇÃO

Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation. Likely to be involved in key signaling pathways crucial for normal limb development. May participate in Wnt signaling

LOCALIZAÇÃO

VIAS BIOLÓGICAS (3)
Antigen processing: Ubiquitination & Proteasome degradationNeddylationAssociation of TriC/CCT with target proteins during biosynthesis
MECANISMO DE DOENÇA

Split-hand/foot malformation 3

A limb malformation involving the central rays of the autopod and presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. Some patients have been found to have intellectual disability, ectodermal and craniofacial findings, and orofacial clefting.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
79.1 TPM
Cólon sigmoide
66.1 TPM
Esôfago - Muscular
60.6 TPM
Nervo tibial
59.9 TPM
Próstata
59.2 TPM
OUTRAS DOENÇAS (1)
split hand-foot malformation
HGNC:10847UniProt:P57775
LYSETLysosomal enzyme trafficking factorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for mannose-6-phosphate-dependent trafficking of lysosomal enzymes (PubMed:36074821, PubMed:36074822, PubMed:36096887). LYSET bridges GlcNAc-1-phosphate transferase (GNPTAB), to the membrane-bound transcription factor site-1 protease (MBTPS1), thus allowing proteolytic activation of the GNPTAB. GNPTAB is involved in the regulation of M6P-dependent Golgi-to-lysosome trafficking of lysosomal enzymes (PubMed:36074821, PubMed:36074822, PubMed:36096887). LYSET is thus an essential factor for

LOCALIZAÇÃO

Golgi apparatus membrane

MECANISMO DE DOENÇA

Dysostosis multiplex, Ain-Naz type

An autosomal recessive, severe skeletal disease characterized by features of dysostosis multiplex, severe short stature, coarse facies with broad nose and prominent lips, protruding abdomens, and progressive skeletal changes causing gradual mobility loss. Death in childhood or early adulthood may occur.

OUTRAS DOENÇAS (1)
dysostosis multiplex, Ain-Naz type
HGNC:HGNC:20218UniProt:Q8N6I4
EOGTEGF domain-specific O-linked N-acetylglucosamine transferaseCandidate gene tested inTolerante
FUNÇÃO

Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in extracellular proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc). Specifically glycosylates the Thr residue located between the fifth and sixth conserved cysteines of folded EGF-like domains

LOCALIZAÇÃO

Endoplasmic reticulum lumen

MECANISMO DE DOENÇA

Adams-Oliver syndrome 4

A form of Adams-Oliver syndrome, a disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
73.6 TPM
Artéria tibial
56.9 TPM
Artéria coronária
52.8 TPM
Esôfago - Muscular
43.4 TPM
Pulmão
39.1 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
Adams-Oliver syndrome 4Adams-Oliver syndrome
HGNC:28526UniProt:Q5NDL2
GDF6Growth/differentiation factor 6Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Growth factor that controls proliferation and cellular differentiation in the retina and bone formation. Plays a key role in regulating apoptosis during retinal development. Establishes dorsal-ventral positional information in the retina and controls the formation of the retinotectal map (PubMed:23307924). Required for normal formation of bones and joints in the limbs, skull, digits and axial skeleton. Plays a key role in establishing boundaries between skeletal elements during development. Regu

LOCALIZAÇÃO

Secreted

MECANISMO DE DOENÇA

Klippel-Feil syndrome 1, autosomal dominant

A skeletal disorder characterized by congenital fusion of cervical vertebrae. It is due to a failure in the normal segmentation of vertebrae during the early weeks of fetal development. The clinical triad consists of short neck, low posterior hairline, and limited neck movement. Deafness is a feature in some cases and may be of sensorineural, conductive, or mixed type.

EXPRESSÃO TECIDUAL(Baixa expressão)
Fibroblastos
2.7 TPM
Útero
2.6 TPM
Coração - Átrio
2.5 TPM
Adipose Visceral Omentum
2.2 TPM
Artéria coronária
2.2 TPM
OUTRAS DOENÇAS (9)
isolated microphthalmia 4multiple synostoses syndrome 4Klippel-Feil syndrome 1, autosomal dominantmicrophthalmia, isolated, with coloboma 6
HGNC:4221UniProt:Q6KF10
TCF12Transcription factor 12Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcriptional regulator. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3') (By similarity). May be involved in the functional network that regulates the development of the GnRH axis (PubMed:32620954)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Negative Regulation of CDH1 Gene TranscriptionRUNX1 regulates transcription of genes involved in differentiation of HSCsNGF-stimulated transcriptionMyogenesisTGFBR3 expression
MECANISMO DE DOENÇA

Craniosynostosis 3

A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
39.7 TPM
Cervix Ectocervix
38.1 TPM
Fibroblastos
37.1 TPM
Útero
32.3 TPM
Nervo tibial
28.4 TPM
OUTRAS DOENÇAS (4)
hypogonadotropic hypogonadism 26 with or without anosmiaTCF12-related craniosynostosisextraskeletal myxoid chondrosarcomaobsolete isolated brachycephaly
HGNC:11623UniProt:Q99081
SKISki oncogeneDisease-causing germline mutation(s) inRestrito
FUNÇÃO

May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Downregulation of SMAD2/3:SMAD4 transcriptional activitySignaling by BMP
MECANISMO DE DOENÇA

Shprintzen-Goldberg craniosynostosis syndrome

A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, intellectual disability, developmental delay and learning disabilities.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
235.4 TPM
Cerebelo
233.1 TPM
Artéria tibial
154.4 TPM
Aorta
150.9 TPM
Útero
107.2 TPM
OUTRAS DOENÇAS (2)
Shprintzen-Goldberg syndromechromosome 1p36 deletion syndrome
HGNC:10896UniProt:P12755
EPS15L1Epidermal growth factor receptor substrate 15-like 1Candidate gene tested inAltamente restrito
FUNÇÃO

Seems to be a constitutive component of clathrin-coated pits that is required for receptor-mediated endocytosis. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2

LOCALIZAÇÃO

Cell membraneNucleusMembrane, coated pit

VIAS BIOLÓGICAS (3)
EGFR downregulationClathrin-mediated endocytosisCargo recognition for clathrin-mediated endocytosis
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
31.1 TPM
Cérebro - Hemisfério cerebelar
30.0 TPM
Músculo esquelético
27.9 TPM
Cervix Ectocervix
23.6 TPM
Cervix Endocervix
20.9 TPM
OUTRAS DOENÇAS (1)
split hand-foot malformation
HGNC:24634UniProt:Q9UBC2
TBX6T-box transcription factor TBX6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

T-box transcription factor that plays an essential role in the determination of the fate of axial stem cells: neural vs mesodermal. Acts in part by down-regulating, a specific enhancer (N1) of SOX2, to inhibit neural development. Seems to play also an essential role in left/right axis determination and acts through effects on Notch signaling around the node as well as through an effect on the morphology and motility of the nodal cilia (By similarity)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
Formation of paraxial mesodermSomitogenesisFormation of the posterior neural plate
MECANISMO DE DOENÇA

Spondylocostal dysostosis 5

A rare condition of variable severity characterized by vertebral and costal anomalies. The main feature include dwarfism, vertebral fusion, hemivertebrae, posterior rib fusion, reduced rib number, and other rib malformations. SCDO5 inheritance can be autosomal dominant or recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
10.7 TPM
Vagina
7.6 TPM
Bladder
4.0 TPM
Tireoide
3.8 TPM
Skin Not Sun Exposed Suprapubic
3.4 TPM
OUTRAS DOENÇAS (3)
spondylocostal dysostosis 5autosomal recessive spondylocostal dysostosisautosomal dominant spondylocostal dysostosis
HGNC:11605UniProt:O95947
TMEM107Transmembrane protein 107Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in cilia formation and embryonic patterning. Requires for normal Sonic hedgehog (Shh) signaling in the neural tube and acts in combination with GLI2 and GLI3 to pattern ventral and intermediate neuronal cell types (By similarity). During ciliogenesis regulates the ciliary transition zone localization of some MKS complex proteins (PubMed:26518474)

LOCALIZAÇÃO

MembraneCell projection, cilium

MECANISMO DE DOENÇA

Meckel syndrome 13

A form of Meckel syndrome, a disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
16.1 TPM
Nervo tibial
14.0 TPM
Tireoide
13.6 TPM
Testículo
13.1 TPM
Linfócitos
10.6 TPM
OUTRAS DOENÇAS (3)
orofaciodigital syndrome 16Meckel syndrome 13Meckel syndrome
HGNC:28128UniProt:Q6UX40
LMNAPrelamin-A/CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:

LOCALIZAÇÃO

Nucleus laminaNucleus envelopeNucleus, nucleoplasmNucleus matrixNucleus speckle

VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Emery-Dreifuss muscular dystrophy 2, autosomal dominant

A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
392.7 TPM
Aorta
300.6 TPM
Skin Not Sun Exposed Suprapubic
297.7 TPM
Skin Sun Exposed Lower leg
272.6 TPM
Útero
255.8 TPM
OUTRAS DOENÇAS (23)
restrictive dermopathy 2familial partial lipodystrophy, Dunnigan typedilated cardiomyopathy-hypergonadotropic hypogonadism syndromemandibuloacral dysplasia with type A lipodystrophy
HGNC:6636UniProt:P02545
EDNRAEndothelin-1 receptorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of binding affinities for ET-A is: ET1 > ET2 >> ET3

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
G alpha (q) signalling eventsPeptide ligand-binding receptors
MECANISMO DE DOENÇA

Mandibulofacial dysostosis with alopecia

A form of mandibulofacial dysostosis, a disorder characterized by malar and mandibular hypoplasia, typically associated with abnormalities of the ears and eyelids. MFDA features include maxillary dysmorphism with dysplastic zygomatic arch, hypoplastic mandible, scalp alopecia, scant eyebrows and eyelashes, severe hypoplasia or aplasia of eyelids, small cupped dysplastic ears, conductive hearing loss, cleft palate, dental anomalies, micrognathia, and limited jaw mobility.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
89.7 TPM
Cervix Endocervix
82.2 TPM
Útero
55.6 TPM
Ovário
50.4 TPM
Fallopian Tube
43.7 TPM
OUTRAS DOENÇAS (3)
mandibulofacial dysostosis with alopeciacystic fibrosismigraine with or without aura, susceptibility to, 1
HGNC:3179UniProt:P25101
IFT140Intraflagellar transport protein 140 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs) (PubMed:20889716, PubMed:22503633). Plays a pivotal role in proper development and function of ciliated cells through its role in ciliogenesis and/or cilium maintenance (PubMed:22503633). Required for the development and maintenance of the outer segments of rod and cone photoreceptor cells. Plays a role in maintenance and the delivery of opsin to

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 9 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. SRTD9 is characterized by phalangeal cone-shaped epiphyses, chronic renal disease, nearly constant retinal dystrophy, and mild radiographic abnormality of the proximal femur. Occasional features include short stature, cerebellar ataxia, and hepatic fibrosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
59.8 TPM
Testículo
47.9 TPM
Pituitária
34.4 TPM
Ovário
31.1 TPM
Cervix Endocervix
29.6 TPM
OUTRAS DOENÇAS (8)
retinitis pigmentosa 80cranioectodermal dysplasia 5short-rib thoracic dysplasia 9 with or without polydactylyJeune syndrome
HGNC:29077UniProt:Q96RY7
CDH3Cadherin-3Candidate gene tested inTolerante
FUNÇÃO

Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Adherens junctions interactions
MECANISMO DE DOENÇA

Hypotrichosis congenital with juvenile macular dystrophy

A disorder characterized by congenital hypotrichosis, early hair loss, and severe degenerative changes of the retinal macula that culminate in blindness during the second to third decade of life.

OUTRAS DOENÇAS (2)
congenital hypotrichosis with juvenile macular dystrophyEEM syndrome
HGNC:1762UniProt:P22223
MESP2Mesoderm posterior protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor with important role in somitogenesis. Defines the rostrocaudal patterning of the somite by participating in distinct Notch pathways. Also regulates the FGF signaling pathway. Specifies the rostral half of the somites. Generates rostro-caudal polarity of somites by down-regulating in the presumptive rostral domain DLL1, a Notch ligand. Participates in the segment border formation by activating in the anterior presomitic mesoderm LFNG, a negative regulator of DLL1-Notch signal

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Somitogenesis
MECANISMO DE DOENÇA

Spondylocostal dysostosis 2, autosomal recessive

A condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf-like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.6 TPM
Brain Frontal Cortex BA9
1.0 TPM
Córtex cerebral
0.9 TPM
Brain Nucleus accumbens basal ganglia
0.9 TPM
Glândula salivar
0.8 TPM
OUTRAS DOENÇAS (2)
spondylocostal dysostosis 2, autosomal recessiveautosomal recessive spondylocostal dysostosis
HGNC:29659UniProt:Q0VG99
RAB34Ras-related protein Rab-34, isoform NARRDisease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

NucleusNucleus, nucleolus

VIAS BIOLÓGICAS (1)
RAB geranylgeranylation
VIAS REACTOME (2)
EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
198.1 TPM
Ovário
192.1 TPM
Cervix Ectocervix
184.4 TPM
Fibroblastos
182.2 TPM
Cervix Endocervix
181.7 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
orofaciodigital syndrome 20
HGNC:HGNC:16519UniProt:P0DI83
WNT10BProtein Wnt-10bDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Member of the Wnt ligand gene family that encodes for secreted proteins, which activate the Wnt signaling cascade. Specifically activates canonical Wnt/beta-catenin signaling and thus triggers beta-catenin/LEF/TCF-mediated transcriptional programs. Involved in signaling networks controlling stemness, pluripotency and cell fate decisions. Acts in the immune system, mammary gland, adipose tissue, bone and skin

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
MECANISMO DE DOENÇA

Split-hand/foot malformation 6

A limb malformation involving the central rays of the autopod and presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. Some patients have been found to have intellectual disability, ectodermal and craniofacial findings, and orofacial clefting.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
36.1 TPM
Córtex cerebral
29.0 TPM
Brain Frontal Cortex BA9
26.8 TPM
Brain Anterior cingulate cortex BA24
21.3 TPM
Brain Caudate basal ganglia
17.6 TPM
OUTRAS DOENÇAS (4)
tooth agenesis, selective, 8split hand-foot malformation 6tooth agenesissplit hand-foot malformation
HGNC:12775UniProt:O00744
FGFR2Fibroblast growth factor receptor 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is

LOCALIZAÇÃO

Cell membraneGolgi apparatusCytoplasmic vesicleSecreted

VIAS BIOLÓGICAS (1)
Signaling by FGFR2 amplification mutants
MECANISMO DE DOENÇA

Crouzon syndrome

An autosomal dominant syndrome characterized by craniosynostosis, hypertelorism, exophthalmos and external strabismus, parrot-beaked nose, short upper lip, hypoplastic maxilla, and a relative mandibular prognathism.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
130.1 TPM
Útero
43.5 TPM
Skin Sun Exposed Lower leg
41.0 TPM
Cólon sigmoide
39.0 TPM
Skin Not Sun Exposed Suprapubic
37.3 TPM
OUTRAS DOENÇAS (15)
Saethre-Chotzen syndromegastric cancerJackson-Weiss syndromePfeiffer syndrome
HGNC:3689UniProt:P21802
FGFR1Fibroblast growth factor receptor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activati

LOCALIZAÇÃO

Cell membraneNucleusCytoplasm, cytosolCytoplasmic vesicle

VIAS BIOLÓGICAS (2)
Epithelial-Mesenchymal Transition (EMT) during gastrulationFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Pfeiffer syndrome

A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
144.8 TPM
Ovário
142.9 TPM
Artéria tibial
134.1 TPM
Fallopian Tube
122.3 TPM
Cérebro - Hemisfério cerebelar
122.0 TPM
OUTRAS DOENÇAS (20)
Hartsfield-Bixler-Demyer syndromeencephalocraniocutaneous lipomatosisosteoglophonic dysplasiaPfeiffer syndrome
HGNC:3688UniProt:P11362
PDE3AcGMP-inhibited 3',5'-cyclic phosphodiesterase 3ADisease-causing germline mutation(s) inRestrito
FUNÇÃO

Cyclic nucleotide phosphodiesterase with specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:1315035, PubMed:25961942, PubMed:8155697, PubMed:8695850). Also has activity toward cUMP (PubMed:27975297). Independently of its catalytic activity it is part of an E2/17beta-estradiol-induced pro-apoptotic signaling pathway. E2 stabilizes the PDE3A/SLFN12 complex in the cytosol, promoting the dephosphorylation of SLFN12 and acti

LOCALIZAÇÃO

MembraneCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
G alpha (s) signalling events
MECANISMO DE DOENÇA

Hypertension and brachydactyly syndrome

A syndrome characterized by brachydactyly type E, severe salt-independent but age-dependent hypertension, an increased fibroblast growth rate, neurovascular contact at the rostral-ventrolateral medulla, and altered baroreflex blood pressure regulation. It results in death from stroke before age 50 years when untreated. Brachydactyly type E is characterized by shortening of the fingers mainly in the metacarpals and metatarsals.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
66.1 TPM
Aorta
47.5 TPM
Artéria coronária
46.6 TPM
Esôfago - Junção
37.5 TPM
Esôfago - Muscular
34.5 TPM
OUTRAS DOENÇAS (1)
brachydactyly-arterial hypertension syndrome
HGNC:8778UniProt:Q14432
EFTUD2116 kDa U5 small nuclear ribonucleoprotein componentDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Required for pre-mRNA splicing as component of the spliceosome, including pre-catalytic, catalytic and post-catalytic spliceosomal complexes (PubMed:25092792, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154). Component of the U5 snRNP and the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome (PubMed:16723661). As a component of the minor spliceosome, involved in the splicing of U12-type introns i

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Mandibulofacial dysostosis with microcephaly

A rare syndrome characterized by progressive microcephaly, midface and malar hypoplasia, micrognathia, microtia, dysplastic ears, preauricular skin tags, significant developmental delay, and speech delay. Many patients have major sequelae, including choanal atresia that results in respiratory difficulties, conductive hearing loss, and cleft palate.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
75.3 TPM
Fibroblastos
61.4 TPM
Testículo
47.4 TPM
Baço
43.1 TPM
Skin Sun Exposed Lower leg
38.3 TPM
OUTRAS DOENÇAS (1)
mandibulofacial dysostosis-microcephaly syndrome
HGNC:30858UniProt:Q15029
GLI3Transcriptional activator GLI3Candidate gene tested inAltamente restrito
FUNÇÃO

Has a dual function as a transcriptional activator and a repressor of the sonic hedgehog (Shh) pathway, and plays a role in limb development. The full-length GLI3 form (GLI3FL) after phosphorylation and nuclear translocation, acts as an activator (GLI3A) while GLI3R, its C-terminally truncated form, acts as a repressor. A proper balance between the GLI3 activator and the repressor GLI3R, rather than the repressor gradient itself or the activator/repressor ratio gradient, specifies limb digit num

LOCALIZAÇÃO

NucleusCytoplasmCell projection, cilium

VIAS BIOLÓGICAS (2)
GLI3 is processed to GLI3R by the proteasomeHedgehog 'off' state
MECANISMO DE DOENÇA

Greig cephalo-poly-syndactyly syndrome

Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
27.0 TPM
Cólon sigmoide
21.9 TPM
Fallopian Tube
19.5 TPM
Ovário
19.4 TPM
Cervix Ectocervix
15.9 TPM
OUTRAS DOENÇAS (8)
Pallister-Hall syndromepolysyndactyly 4polydactyly, postaxial, type A1Greig cephalopolysyndactyly syndrome
HGNC:4319UniProt:P10071
FGF9Fibroblast growth factor 9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. May have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (10)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerPI-3K cascade:FGFR3Negative regulation of FGFR3 signaling
MECANISMO DE DOENÇA

Multiple synostoses syndrome 3

A bone disease characterized by multiple progressive joint fusions that commonly involve proximal interphalangeal, tarsal-carpal, humeroradial and cervical spine joints. Additional features can include progressive conductive deafness and facial dysmorphism.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
29.8 TPM
Cerebelo
24.4 TPM
Rim - Medula
13.8 TPM
Brain Frontal Cortex BA9
7.3 TPM
Rim - Córtex
6.2 TPM
OUTRAS DOENÇAS (2)
multiple synostoses syndrome 3multiple synostoses syndrome
HGNC:3687UniProt:P31371
HES7Transcription factor HES-7Candidate gene tested inModerado
FUNÇÃO

Transcriptional repressor. Represses transcription from both N box- and E box-containing promoters. May with HES1, cooperatively regulate somite formation in the presomitic mesoderm (PSM). May function as a segmentation clock, which is essential for coordinated somite segmentation (By similarity)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Somitogenesis
MECANISMO DE DOENÇA

Spondylocostal dysostosis 4, autosomal recessive

A rare condition of variable severity characterized by vertebral and costal anomalies. The main feature include dwarfism, vertebral fusion, hemivertebrae, posterior rib fusion, reduced rib number, and other rib malformations.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
7.0 TPM
Cérebro - Hemisfério cerebelar
5.8 TPM
Linfócitos
3.0 TPM
Nervo tibial
2.0 TPM
Córtex cerebral
1.5 TPM
OUTRAS DOENÇAS (2)
spondylocostal dysostosis 4, autosomal recessiveautosomal recessive spondylocostal dysostosis
HGNC:15977UniProt:Q9BYE0
RBM8ARNA-binding protein 8ADisease-causing germline mutation(s) inRestrito
FUNÇÃO

Required for pre-mRNA splicing as component of the spliceosome (PubMed:28502770, PubMed:29301961). Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon juncti

LOCALIZAÇÃO

NucleusNucleus speckleCytoplasm

VIAS BIOLÓGICAS (4)
Transport of Mature mRNA derived from an Intron-Containing TranscriptmRNA 3'-end processingRNA Polymerase II Transcription TerminationmRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Thrombocytopenia-absent radius syndrome

An autosomal recessive disorder characterized by bilateral absence of the radii with the presence of both thumbs, thrombocytopenia, low numbers of megakaryocytes, and bleeding episodes in the first year of life. Thrombocytopenic episodes decrease with age. Skeletal anomalies range from absence of radii to virtual absence of upper limbs, with or without lower limb defects such as malformations of the hip and knee.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
48.5 TPM
Linfócitos
43.6 TPM
Esôfago - Mucosa
42.4 TPM
Fibroblastos
39.4 TPM
Músculo esquelético
39.1 TPM
OUTRAS DOENÇAS (1)
thrombocytopenia-absent radius syndrome
HGNC:9905UniProt:Q9Y5S9
KAT6BHistone acetyltransferase KAT6BDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Histone acetyltransferase which may be involved in both positive and negative regulation of transcription. Required for RUNX2-dependent transcriptional activation. May be involved in cerebral cortex development. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
HATs acetylate histones
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
16.6 TPM
Útero
15.5 TPM
Cervix Ectocervix
14.7 TPM
Cervix Endocervix
14.3 TPM
Nervo tibial
13.5 TPM
OUTRAS DOENÇAS (2)
blepharophimosis - intellectual disability syndrome, SBBYS typegenitopatellar syndrome
HGNC:17582UniProt:Q8WYB5
DHODHDihydroorotate dehydrogenase (quinone), mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. Required for UMP biosynthesis via de novo pathway

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Pyrimidine biosynthesis
MECANISMO DE DOENÇA

Postaxial acrofacial dysostosis

An autosomal recessive syndrome characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
43.8 TPM
Linfócitos
8.6 TPM
Nervo tibial
7.5 TPM
Coração - Átrio
7.3 TPM
Fallopian Tube
7.1 TPM
OUTRAS DOENÇAS (1)
postaxial acrofacial dysostosis
HGNC:2867UniProt:Q02127
NOGNogginDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite. Essential for cartilage morphogenesis and joint formation. Inhibits chondrocyte differentiation through its interaction with GDF5 and, probably, GDF6 (PubMed:21976273, PubMed:26643732)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Signaling by BMPFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Symphalangism, proximal 1A

A disease characterized by the hereditary absence of the proximal interphalangeal joints. Distal interphalangeal joints are less frequently involved and metacarpophalangeal joints are rarely affected whereas carpal bone malformation and fusion are common. In the lower extremities, tarsal bone coalition is common. Conductive hearing loss is seen and is due to fusion of the stapes to the petrous part of the temporal bone.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cervix Ectocervix
8.8 TPM
Cervix Endocervix
7.5 TPM
Nervo tibial
7.2 TPM
Brain Nucleus accumbens basal ganglia
6.3 TPM
Brain Caudate basal ganglia
4.9 TPM
OUTRAS DOENÇAS (7)
multiple synostoses syndrome 1proximal symphalangism 1Abrachydactyly type B2stapes ankylosis with broad thumbs and toes
HGNC:7866UniProt:Q13253
HOXA11Homeobox protein Hox-A11Candidate gene tested inRestrito
FUNÇÃO

Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Formation of the ureteric bud
MECANISMO DE DOENÇA

Radioulnar synostosis with amegakaryocytic thrombocytopenia 1

The syndrome consists of an unusual association of bone marrow failure and skeletal defects. Patients have the same skeletal defects, the proximal fusion of the radius and ulna, resulting in extremely limited pronation and supination of the forearm. Some patients have also symptomatic thrombocytopenia, with bruising and bleeding problems since birth, necessitating correction by bone marrow or umbilical-cord stem-cell transplantation.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
200.7 TPM
Cervix Endocervix
111.2 TPM
Cervix Ectocervix
58.5 TPM
Cólon sigmoide
50.9 TPM
Bladder
41.0 TPM
OUTRAS DOENÇAS (2)
radioulnar synostosis with amegakaryocytic thrombocytopenia 1radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome
HGNC:5101UniProt:P31270
TP63Tumor protein 63Candidate gene tested inAltamente restrito
FUNÇÃO

Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (9)
TP53 Regulates Transcription of Genes Involved in Cytochrome C ReleaseRegulation of TP53 Activity through Association with Co-factorsActivation of PUMA and translocation to mitochondriaTP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertainTP53 Regulates Transcription of Death Receptors and Ligands
MECANISMO DE DOENÇA

Acro-dermato-ungual-lacrimal-tooth syndrome

A form of ectodermal dysplasia. Ectodermal dysplasia defines a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. ADULT syndrome involves ectrodactyly, syndactyly, finger- and toenail dysplasia, hypoplastic breasts and nipples, intensive freckling, lacrimal duct atresia, frontal alopecia, primary hypodontia and loss of permanent teeth. ADULT syndrome differs significantly from EEC3 syndrome by the absence of facial clefting. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
138.8 TPM
Skin Sun Exposed Lower leg
115.7 TPM
Vagina
77.8 TPM
Esôfago - Mucosa
71.8 TPM
Próstata
17.5 TPM
OUTRAS DOENÇAS (15)
orofacial cleft 8limb-mammary syndromepremature ovarian failure 21ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
HGNC:15979UniProt:Q9H3D4
SALL4Sal-like protein 4Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (3)
Transcriptional regulation of pluripotent stem cellsRegulation of PTEN gene transcriptionPOU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
MECANISMO DE DOENÇA

Duane-radial ray syndrome

Disorder characterized by the association of forearm malformations with Duane retraction syndrome.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
11.9 TPM
Testículo
8.9 TPM
Próstata
3.7 TPM
Pâncreas
1.3 TPM
Glândula salivar
1.2 TPM
OUTRAS DOENÇAS (5)
Duane-radial ray syndromeIVIC syndromeOkihiro syndrome due to 20q13 microdeletionOkihiro syndrome due to a point mutation
HGNC:15924UniProt:Q9UJQ4
CREBBPCREB-binding proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acetylates histones, giving a specific tag for transcriptional activation (PubMed:21131905, PubMed:24616510). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed:21131905). Also acetylates non-histone proteins, like DDX21, FBL, IRF2, MAFG, NCOA3, POLR1E/PAF53 and FOXO1 (PubMed:10490106, PubMed:11154691, PubMed:12738767, PubMed:12929931, PubMed:24207024, PubMed:28790157, PubMed:30540930, PubMed:35675826, PubMed:9707565). Binds specifically to ph

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
SARS-CoV-2 activates/modulates innate and adaptive immune responses
EXPRESSÃO TECIDUAL(Ubíquo)
Útero
53.4 TPM
Ovário
49.6 TPM
Cervix Endocervix
48.1 TPM
Cerebelo
45.0 TPM
Artéria tibial
41.8 TPM
OUTRAS DOENÇAS (5)
Menke-Hennekam syndrome 1Rubinstein-Taybi syndrome due to CREBBP mutationsMenke-Hennekam syndromeacute myeloid leukemia with t(8;16)(p11;p13) translocation
HGNC:2348UniProt:Q92793
PAX1Paired box protein Pax-1Candidate gene tested inTolerante
FUNÇÃO

This protein is a transcriptional activator. It may play a role in the formation of segmented structures of the embryo. May play an important role in the normal development of the vertebral column (By similarity)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Nonhomologous End-Joining (NHEJ)
MECANISMO DE DOENÇA

Otofaciocervical syndrome 2, with T-cell deficiency

An autosomal recessive disorder characterized by facial dysmorphism, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies including vertebral defects, low-set clavicles, winged scapulae, sloping shoulders, and mild intellectual disability. Some patients also exhibit altered thymus development with T-cell immunodeficiency.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
0.6 TPM
Skin Sun Exposed Lower leg
0.3 TPM
Esôfago - Mucosa
0.2 TPM
Músculo esquelético
0.2 TPM
Skin Not Sun Exposed Suprapubic
0.1 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
otofaciocervical syndrome 2otofaciocervical syndrome
HGNC:8615UniProt:P15863
TCTN3Tectonic-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Part of the tectonic-like complex which is required for tissue-specific ciliogenesis and may regulate ciliary membrane composition (By similarity). May be involved in apoptosis regulation. Necessary for signal transduction through the sonic hedgehog (Shh) signaling pathway

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Orofaciodigital syndrome 4

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD4 patients have tongue nodules, multiple frenulae, broad flat nose, hypertelorism, and short rib polydactyly with tibial dysplasia (Majewski syndrome). The presence of severe tibial aplasia differentiates OFD4 from OFD1. Additional features of cystic dysplastic kidneys and brain malformation, including occipital encephalocele, are observed in severely affected patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
62.2 TPM
Tireoide
59.1 TPM
Ovário
54.1 TPM
Cervix Endocervix
50.4 TPM
Útero
50.0 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 18orofaciodigital syndrome IVMeckel syndromeJoubert syndrome
HGNC:24519UniProt:Q6NUS6
SF3B4Splicing factor 3B subunit 4Candidate gene tested inAltamente restrito
FUNÇÃO

Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:10882114, PubMed:12234937, PubMed:27720643, PubMed:32494006). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:12234937

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
Dengue Virus-Host InteractionsmRNA Splicing - Major PathwaymRNA PolyadenylationmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Acrofacial dysostosis 1, Nager type

A form of acrofacial dysostosis, a group of disorders which are characterized by malformation of the craniofacial skeleton and the limbs. The major facial features of AFD1 include downslanted palpebral fissures, midface retrusion, and micrognathia, the latter of which often requires the placement of a tracheostomy in early childhood. Limb defects typically involve the anterior (radial) elements of the upper limbs and manifest as small or absent thumbs, triphalangeal thumbs, radial hyoplasia or aplasia, and radioulnar synostosis. Phocomelia of the upper limbs and, occasionally, lower-limb defects have also been reported.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
104.6 TPM
Útero
91.1 TPM
Fallopian Tube
88.0 TPM
Artéria tibial
87.2 TPM
Fibroblastos
86.7 TPM
OUTRAS DOENÇAS (2)
Nager acrofacial dysostosisacrofacial dysostosis Rodriguez type
HGNC:10771UniProt:Q15427
TBX5T-box transcription factor TBX5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

DNA-binding protein that regulates the transcription of several genes and is involved in heart development and limb pattern formation (PubMed:25725155, PubMed:25963046, PubMed:26917986, PubMed:27035640, PubMed:29174768, PubMed:8988164). Binds to the core DNA motif of NPPA promoter (PubMed:26926761)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (3)
YAP1- and WWTR1 (TAZ)-stimulated gene expressionPhysiological factorsCardiogenesis
MECANISMO DE DOENÇA

Holt-Oram syndrome

Developmental disorder affecting the heart and upper limbs. It is characterized by thumb anomaly and atrial septal defects.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
71.0 TPM
Pulmão
35.0 TPM
Esôfago - Muscular
20.7 TPM
Esôfago - Junção
15.3 TPM
Coração - Ventrículo esquerdo
14.7 TPM
OUTRAS DOENÇAS (2)
Holt-Oram syndromefamilial long QT syndrome
HGNC:11604UniProt:Q99593
DLX5Homeobox protein DLX-5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. Promotes cell proliferation by up-regulating MYC promoter activity. Involved as a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondra

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
Regulation of RUNX2 expression and activitySpecification of the neural plate borderDevelopmental Lineage of Mammary Stem Cells
MECANISMO DE DOENÇA

Split-hand/foot malformation 1 with sensorineural hearing loss, autosomal recessive

A disease characterized by the association of split-hand/foot malformation with deafness. Split-hand/foot malformation is a limb malformation involving the central rays of the autopod and presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. Some patients have been found to have intellectual disability, ectodermal and craniofacial findings, and orofacial clefting.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
34.7 TPM
Skin Not Sun Exposed Suprapubic
30.0 TPM
Brain Caudate basal ganglia
7.3 TPM
Brain Nucleus accumbens basal ganglia
7.1 TPM
Brain Putamen basal ganglia
5.7 TPM
OUTRAS DOENÇAS (3)
split hand-foot malformation 1split hand-foot malformation 1 with sensorineural hearing losssplit hand-foot malformation
HGNC:2918UniProt:P56178
RIPPLY2Protein ripply2Candidate gene tested inTolerante
FUNÇÃO

Plays a role in somitogenesis. Required for somite segregation and establishment of rostrocaudal polarity in somites (By similarity)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Somitogenesis
MECANISMO DE DOENÇA

Spondylocostal dysostosis 6, autosomal recessive

A form of spondylocostal dysostosis, a condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf-like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
38.3 TPM
Cerebelo
29.7 TPM
Brain Frontal Cortex BA9
17.6 TPM
Brain Nucleus accumbens basal ganglia
16.2 TPM
Pituitária
12.6 TPM
OUTRAS DOENÇAS (2)
spondylocostal dysostosis 6, autosomal recessiveautosomal recessive spondylocostal dysostosis
HGNC:21390UniProt:Q5TAB7
SCNM1Sodium channel modifier 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (PubMed:36084634). Plays a role in the regulation of primary cilia length and Hedgehog signaling (PubMed:36084634)

LOCALIZAÇÃO

Nucleus, nucleoplasmNucleus speckle

MECANISMO DE DOENÇA

Orofaciodigital syndrome 19

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD19 is an autosomal recessive form characterized by tongue nodules, dental and digital anomalies, narrow high-arched or cleft palate, and retrognathia. Some patients have notching of the upper or lower lip.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
25.6 TPM
Linfócitos
24.8 TPM
Cérebro - Hemisfério cerebelar
21.9 TPM
Útero
21.6 TPM
Cervix Endocervix
21.6 TPM
OUTRAS DOENÇAS (1)
orofaciodigital syndrome 19
HGNC:HGNC:23136UniProt:Q9BWG6
TBC1D32Protein broad-mindedDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for high-level Shh responses in the developing neural tube. Together with CDK20, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to Shh signaling (By similarity)

LOCALIZAÇÃO

CytoplasmCell projection, cilium

MECANISMO DE DOENÇA

Orofaciodigital syndrome 9

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD9 is an autosomal recessive form characterized by a variable phenotype. Clinical features are midline defects, including abnormal pituitary development that results in variable pituitary hormone deficiencies, facial dysmorphic features including frontal bossing and hypertelorism, and variable eye defects including microphthalmia, coloboma, and retinal dystrophy. Affected individuals manifest variable psychomotor development.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Pituitária
6.4 TPM
Nervo tibial
4.4 TPM
Linfócitos
4.0 TPM
Cervix Endocervix
4.0 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
orofaciodigital syndrome IX
HGNC:21485UniProt:Q96NH3
WNT7AProtein Wnt-7aCandidate gene tested inTolerante
FUNÇÃO

Ligand for members of the frizzled family of seven transmembrane receptors that functions in the canonical Wnt/beta-catenin signaling pathway (By similarity). Plays an important role in embryonic development, including dorsal versus ventral patterning during limb development, skeleton development and urogenital tract development (PubMed:16826533). Required for central nervous system (CNS) angiogenesis and blood-brain barrier regulation (PubMed:30026314). Required for normal, sexually dimorphic d

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
MECANISMO DE DOENÇA

Limb pelvis hypoplasia aplasia syndrome

A syndrome of severe deficiency of the extremities due to hypo- or aplasia of one or more long bones of one or more limbs. Pelvic manifestations include hip dislocation, hypoplastic iliac bone and aplastic pubic bones. Thoracic deformity, unusual facies and genitourinary anomalies can be present.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
4.2 TPM
Córtex cerebral
4.1 TPM
Testículo
3.1 TPM
Brain Caudate basal ganglia
3.0 TPM
Cérebro - Amígdala
3.0 TPM
OUTRAS DOENÇAS (3)
Fuhrmann syndromeSantos syndromephocomelia, Schinzel type
HGNC:12786UniProt:O00755
ALX4Homeobox protein aristaless-like 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor involved in skull and limb development. Plays an essential role in craniofacial development, skin and hair follicle development

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Parietal foramina 2

Autosomal dominant disease characterized by oval defects of the parietal bones caused by deficient ossification around the parietal notch, which is normally obliterated during the fifth fetal month. PFM2 is also a clinical feature of Potocki-Shaffer syndrome.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (6)
frontonasal dysplasia with alopecia and genital anomalyparietal foramina 2Potocki-Shaffer syndromeparietal foramina
HGNC:450UniProt:Q9H161
C2CD3C2 domain-containing protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the centrioles that acts as a positive regulator of centriole elongation (PubMed:24997988). Promotes assembly of centriolar distal appendage, a structure at the distal end of the mother centriole that acts as an anchor of the cilium, and is required for recruitment of centriolar distal appendages proteins CEP83, SCLT1, CEP89, FBF1 and CEP164. Not required for centriolar satellite integrity or RAB8 activation. Required for primary cilium formation (PubMed:23769972). Required for soni

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Orofaciodigital syndrome 14

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD14 patients show severe microcephaly, cerebral malformations the molar tooth sign, and intellectual disability in addition to canonical OFDS features.

OUTRAS DOENÇAS (1)
orofaciodigital syndrome type 14
HGNC:24564UniProt:Q4AC94
HOXA13Homeobox protein Hox-A13Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Sequence-specific, AT-rich binding transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Hand-foot-genital syndrome

A disorder characterized by limb and genitourinary anomalies. Clinical features include small feet with unusually short great toes and abnormal thumbs. Females with the disorder have duplication of the genital tract.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cervix Ectocervix
71.9 TPM
Cervix Endocervix
59.2 TPM
Vagina
30.5 TPM
Bladder
30.0 TPM
Próstata
26.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
hand-foot-genital syndromeGuttmacher syndrome
HGNC:5102UniProt:P31271
ZRSR2U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pre-mRNA-binding protein required for splicing of both U2- and U12-type introns. Selectively interacts with the 3'-splice site of U2- and U12-type pre-mRNAs and promotes different steps in U2 and U12 intron splicing. Recruited to U12 pre-mRNAs in an ATP-dependent manner and is required for assembly of the pre-spliceosome, a precursor to other spliceosomal complexes. For U2-type introns, it is selectively and specifically required for the second step of splicing

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
mRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Orofaciodigital syndrome 21

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD21 is an X-linked recessive form characterized by postaxial polydactyly of the hands, hallux duplication, palatal defects, fused incisors, accessory oral frenula and tongue nodules, in association with brain anomalies that range from pituitary anomalies to alobar holoprosencephaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
38.9 TPM
Baço
38.0 TPM
Cervix Endocervix
37.6 TPM
Cervix Ectocervix
36.3 TPM
Artéria tibial
34.9 TPM
OUTRAS DOENÇAS (1)
orofaciodigital syndrome 21
HGNC:HGNC:23019UniProt:Q15696
FGFR3Fibroblast growth factor receptor 3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferat

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicleEndoplasmic reticulumSecreted

VIAS BIOLÓGICAS (2)
Signaling by FGFR3 in diseaset(4;14) translocations of FGFR3
MECANISMO DE DOENÇA

Achondroplasia

A frequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. ACH is an autosomal dominant disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
364.6 TPM
Skin Sun Exposed Lower leg
356.5 TPM
Esôfago - Mucosa
199.7 TPM
Brain Caudate basal ganglia
148.4 TPM
Brain Nucleus accumbens basal ganglia
135.4 TPM
OUTRAS DOENÇAS (19)
nevus, epidermalsevere achondroplasia-developmental delay-acanthosis nigricans syndromelacrimoauriculodentodigital syndrome 2testicular germ cell tumor
HGNC:3690UniProt:P22607
SHHSonic hedgehog proteinCandidate gene tested inAltamente restrito
FUNÇÃO

The C-terminal part of the sonic hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity (By similarity). Both activities result in the cleavage of the full-length protein into two parts (ShhN and ShhC) followed by the covalent attachment of a cholesterol moiety to the C-terminal of the newly generated ShhN (By similarity). Both activities occur in the endoplasmic reticulum (By similarity). Once cleaved, ShhC is degraded in the endoplasmic reticulum (By simi

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus membraneSecretedCell membrane

VIAS BIOLÓGICAS (5)
Hedgehog 'on' stateActivation of SMOLigand-receptor interactionsRelease of Hh-Np from the secreting cellFormation of lateral plate mesoderm
MECANISMO DE DOENÇA

Microphthalmia/Coloboma 5

A disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues. Ocular abnormalities like opacities of the cornea and lens, scaring of the retina and choroid, and other abnormalities may also be present. Ocular colobomas are a set of malformations resulting from abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure).

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
21.7 TPM
Glândula adrenal
7.7 TPM
Fígado
7.4 TPM
Estômago
3.8 TPM
Rim - Medula
3.5 TPM
OUTRAS DOENÇAS (15)
microphthalmia, isolated, with coloboma 5holoprosencephaly 3solitary median maxillary central incisor syndrometibia, hypoplasia or aplasia of, with polydactyly
HGNC:10848UniProt:Q15465
EYA1Protein phosphatase EYA1Candidate gene tested inAltamente restrito
FUNÇÃO

Functions both as protein phosphatase and as transcriptional coactivator for SIX1, and probably also for SIX2, SIX4 and SIX5 (By similarity). Tyrosine phosphatase that dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph) and promotes efficient DNA repair via the recruitment of DNA repair complexes containing MDC1. 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress (PubMed

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (2)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksFormation of the ureteric bud
MECANISMO DE DOENÇA

Branchiootorenal syndrome 1

A syndrome characterized by branchial cleft fistulas or cysts, sensorineural and/or conductive hearing loss, pre-auricular pits, structural defects of the outer, middle or inner ear, and renal malformations.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pituitária
22.8 TPM
Próstata
12.2 TPM
Brain Caudate basal ganglia
10.7 TPM
Brain Putamen basal ganglia
10.6 TPM
Cervix Ectocervix
8.1 TPM
OUTRAS DOENÇAS (6)
branchiootic syndrome 1branchiootorenal syndrome 1otofaciocervical syndrome 1otofaciocervical syndrome
HGNC:3519UniProt:Q99502
LMBR1Limb region 1 protein homologCandidate gene tested inTolerante
FUNÇÃO

Putative membrane receptor

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Preaxial polydactyly 2

Polydactyly consists of duplication of the distal phalanx. The thumb in PPD2 is usually opposable and possesses a normal metacarpal.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
16.9 TPM
Testículo
14.8 TPM
Útero
13.0 TPM
Cérebro - Hemisfério cerebelar
12.8 TPM
Ovário
12.4 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (7)
syndactyly type 4laurin-Sandrow syndrometriphalangeal thumb-polysyndactyly syndromeacheiropody
HGNC:13243UniProt:Q8WVP7
DLL3Delta-like protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity)

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
SomitogenesisFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Spondylocostal dysostosis 1, autosomal recessive

A condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf-like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
11.4 TPM
Hipotálamo
8.6 TPM
Cérebro - Amígdala
8.3 TPM
Brain Anterior cingulate cortex BA24
6.8 TPM
Brain Caudate basal ganglia
6.5 TPM
OUTRAS DOENÇAS (2)
spondylocostal dysostosis 1, autosomal recessiveautosomal recessive spondylocostal dysostosis
HGNC:2909UniProt:Q9NYJ7
SEM1Putative protein SEM1, isoform 2Candidate gene tested inRestrito
LOCALIZAÇÃO

VIAS BIOLÓGICAS (10)
Vif-mediated degradation of APOBEC3GVpu mediated degradation of CD4Degradation of GLI2 by the proteasomeDegradation of GLI1 by the proteasomeHedgehog 'on' state
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
22.5 TPM
Linfócitos
22.1 TPM
Fibroblastos
22.0 TPM
Ovário
19.5 TPM
Cervix Endocervix
17.0 TPM
OUTRAS DOENÇAS (1)
split hand-foot malformation
HGNC:10845UniProt:Q6ZVN7
IFT52Intraflagellar transport protein 52 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in ciliogenesis as part of a complex involved in intraflagellar transport (IFT), the bi-directional movement of particles required for the assembly, maintenance and functioning of primary cilia (PubMed:27466190). Required for the anterograde transport of IFT88 (PubMed:27466190)

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 16 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
44.8 TPM
Cervix Ectocervix
43.8 TPM
Cervix Endocervix
43.3 TPM
Testículo
41.5 TPM
Útero
37.8 TPM
OUTRAS DOENÇAS (2)
short-rib thoracic dysplasia 16 with or without polydactylycranioectodermal dysplasia
HGNC:15901UniProt:Q9Y366
GDF5Growth/differentiation factor 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Growth factor involved in bone and cartilage formation. During cartilage development regulates differentiation of chondrogenic tissue through two pathways. Firstly, positively regulates differentiation of chondrogenic tissue through its binding of high affinity with BMPR1B and of less affinity with BMPR1A, leading to induction of SMAD1-SMAD5-SMAD8 complex phosphorylation and then SMAD protein signaling transduction (PubMed:15530414, PubMed:21976273, PubMed:24098149, PubMed:25092592). Secondly, n

LOCALIZAÇÃO

SecretedCell membrane

VIAS BIOLÓGICAS (1)
Molecules associated with elastic fibres
MECANISMO DE DOENÇA

Acromesomelic dysplasia 2A

A form of acromesomelic dysplasia, a skeletal disorder characterized by short stature, very short limbs and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMD2A is an autosomal recessive form characterized by normal axial skeletons and missing or fused skeletal elements within the hands and feet.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
7.0 TPM
Glândula salivar
4.0 TPM
Cólon sigmoide
2.0 TPM
Pulmão
1.8 TPM
Testículo
1.3 TPM
OUTRAS DOENÇAS (13)
multiple synostoses syndrome 2symphalangism, proximal, 1Bbrachydactyly type A2brachydactyly type C
HGNC:4220UniProt:P43026
LFNGBeta-1,3-N-acetylglucosaminyltransferase lunatic fringeDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Modulates NOTCH1 activity by modifying O-fucose residues at specific EGF-like domains resulting in inhibition of NOTCH1 activation by JAG1 and enhancement of NOTCH1 activation by DLL1 via an increase in its binding to DLL1 (By similarity). Decreases the binding of JAG1 to NOTCH2 but not that of DLL1 (PubMed:11346656). Essential mediator of som

LOCALIZAÇÃO

Golgi apparatusGolgi apparatus membrane

VIAS BIOLÓGICAS (3)
Pre-NOTCH Processing in GolgiNephron developmentSomitogenesis
MECANISMO DE DOENÇA

Spondylocostal dysostosis 3, autosomal recessive

A condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf-like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
44.0 TPM
Skin Sun Exposed Lower leg
42.0 TPM
Pâncreas
31.1 TPM
Glândula salivar
25.3 TPM
Baço
24.0 TPM
OUTRAS DOENÇAS (2)
spondylocostal dysostosis 3, autosomal recessiveautosomal recessive spondylocostal dysostosis
HGNC:6560UniProt:Q8NES3
ALX3Homeobox protein aristaless-like 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcriptional regulator with a possible role in patterning of mesoderm during development

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Transcriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Frontonasal dysplasia 1

The term frontonasal dysplasia describes an array of abnormalities affecting the eyes, forehead and nose and linked to midfacial dysraphia. The clinical picture is highly variable. Major findings include true ocular hypertelorism; broadening of the nasal root; median facial cleft affecting the nose and/or upper lip and palate; unilateral or bilateral clefting of the alae nasi; lack of formation of the nasal tip; anterior cranium bifidum occultum; a V-shaped or widow's peak frontal hairline.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
frontorhiny
HGNC:449UniProt:O95076
RNU12Candidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
RNA polymerase II transcribes snRNA genes
OUTRAS DOENÇAS (3)
craniosynostosis-anal anomalies-porokeratosis syndromespinocerebellar ataxia, autosomal recessive 33congenital cerebellar ataxia due to RNU12 mutation
HGNC:19380
GLI2Zinc finger protein GLI2Candidate gene tested inAltamente restrito
FUNÇÃO

Functions as a transcription regulator in the hedgehog (Hh) pathway (PubMed:18455992, PubMed:26565916). Functions as a transcriptional activator (PubMed:19878745, PubMed:24311597, PubMed:9557682). May also function as transcriptional repressor (By similarity). Requires STK36 for full transcriptional activator activity. Required for normal embryonic development (PubMed:15994174, PubMed:20685856) Involved in the smoothened (SHH) signaling pathway Involved in the smoothened (SHH) signaling pathway

LOCALIZAÇÃO

NucleusCytoplasmCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateHedgehog 'on' state
MECANISMO DE DOENÇA

Holoprosencephaly 9

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE9 is characterized by defective anterior pituitary formation and pan-hypopituitarism, with or without overt forebrain cleavage abnormalities, and holoprosencephaly-like midfacial hypoplasia. HPE9 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
22.1 TPM
Útero
11.2 TPM
Cervix Endocervix
10.1 TPM
Cervix Ectocervix
9.0 TPM
Fibroblastos
7.9 TPM
OUTRAS DOENÇAS (8)
postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndromeholoprosencephaly 9combined pituitary hormone deficiencies, genetic formobsolete midline interhemispheric variant of holoprosencephaly
HGNC:4318UniProt:P10070
PRKAR1AcAMP-dependent protein kinase type I-alpha regulatory subunitCandidate gene tested inAltamente restrito
FUNÇÃO

Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (10)
PKA activationGPER1 signalingCREB1 phosphorylation through the activation of Adenylate CyclaseDARPP-32 eventsHigh laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
MECANISMO DE DOENÇA

Carney complex 1

CNC is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
152.7 TPM
Ovário
151.5 TPM
Aorta
138.6 TPM
Útero
138.3 TPM
Tecido adiposo
129.4 TPM
OUTRAS DOENÇAS (9)
familial atrial myxomapigmented nodular adrenocortical disease, primary, 1Acrodysostosis 1 with or without hormone resistanceCarney complex, type 1
HGNC:9388UniProt:P10644
LMX1BLIM homeobox transcription factor 1-betaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor involved in the regulation of podocyte-expressed genes (PubMed:24042019, PubMed:28059119). Essential for the specification of dorsal limb fate at both the zeugopodal and autopodal levels

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Nail-patella syndrome

Disease that cause abnormal skeletal patterning and renal dysplasia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Mama
5.2 TPM
Skin Sun Exposed Lower leg
3.4 TPM
Rim - Córtex
3.2 TPM
Testículo
3.0 TPM
Skin Not Sun Exposed Suprapubic
2.7 TPM
OUTRAS DOENÇAS (3)
nail-patella-like renal diseasenail-patella syndrome9q33.3q34.11 microdeletion syndrome
HGNC:6654UniProt:O60663
MECOMHistone-lysine N-methyltransferase MECOMDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions as a transcriptional regulator binding to DNA sequences in the promoter region of target genes and regulating positively or negatively their expression. Oncogene which plays a role in development, cell proliferation and differentiation. May also play a role in apoptosis through regulation of the JNK and TGF-beta signaling. Involved in hematopoiesis Displays histone methyltransferase activity and monomethylates 'Lys-9' of histone H3 (H3K9me1). Probably catalyzes the monomethylation of f

LOCALIZAÇÃO

NucleusNucleus speckleCytoplasm

VIAS BIOLÓGICAS (2)
Regulation of PTEN gene transcriptionFormation of the nephric duct
EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
33.9 TPM
Rim - Medula
23.4 TPM
Pulmão
15.6 TPM
Aorta
14.7 TPM
Tecido adiposo
14.4 TPM
OUTRAS DOENÇAS (3)
radioulnar synostosis with amegakaryocytic thrombocytopenia 2radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndromeacute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)
HGNC:3498UniProt:Q03112
DDX59Probable ATP-dependent RNA helicase DDX59Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Orofaciodigital syndrome 5

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD5 patients show the core features of cleft palate, lobulated tongue, and polydactyly. Additional features include frontal bossing and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
17.3 TPM
Cervix Endocervix
14.8 TPM
Útero
14.5 TPM
Ovário
14.4 TPM
Fallopian Tube
14.1 TPM
OUTRAS DOENÇAS (1)
orofaciodigital syndrome V
HGNC:25360UniProt:Q5T1V6
MAP3K20Mitogen-activated protein kinase kinase kinase 20Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Stress-activated component of a protein kinase signal transduction cascade that promotes programmed cell death in response to various stress, such as ribosomal stress, osmotic shock and ionizing radiation (PubMed:10924358, PubMed:11836244, PubMed:12220515, PubMed:14521931, PubMed:15350844, PubMed:15737997, PubMed:18331592, PubMed:20559024, PubMed:26999302, PubMed:32289254, PubMed:32610081, PubMed:35857590). Acts by catalyzing phosphorylation of MAP kinase kinases, leading to activation of the JN

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Split-foot malformation with mesoaxial polydactyly

An autosomal recessive disorder characterized by a split-foot defect, mesoaxial polydactyly, nail abnormalities of the hands, and sensorineural hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
113.8 TPM
Músculo esquelético
111.2 TPM
Esôfago - Junção
104.4 TPM
Cólon sigmoide
84.9 TPM
Artéria tibial
74.7 TPM
OUTRAS DOENÇAS (3)
split-foot malformation-mesoaxial polydactyly syndromemyopathy, centronuclear, 6, with fiber-type disproportioncongenital fiber-type disproportion myopathy
HGNC:17797UniProt:Q9NYL2
SPECC1LCytospin-ACandidate gene tested inAltamente restrito
FUNÇÃO

Involved in cytokinesis and spindle organization. May play a role in actin cytoskeleton organization and microtubule stabilization and hence required for proper cell adhesion and migration

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytoskeleton, spindleCell junction, gap junction

MECANISMO DE DOENÇA

Facial clefting, oblique, 1

A rare form of facial clefting. A facial cleft is any of the fissures between the embryonic prominences that normally unite to form the face.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.8 TPM
Esôfago - Muscular
43.6 TPM
Artéria tibial
43.1 TPM
Cérebro - Hemisfério cerebelar
41.4 TPM
Útero
41.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (3)
Tessier number 4 facial cleftTeebi hypertelorism syndrome 1commissural facial cleft
HGNC:29022UniProt:Q69YQ0
CPLANE1Ciliogenesis and planar polarity effector 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in ciliogenesis (PubMed:25877302, PubMed:35582950). Involved in the establishment of cell polarity required for directional cell migration. Proposed to act in association with the CPLANE (ciliogenesis and planar polarity effectors) complex. Involved in recruitment of peripheral IFT-A proteins to basal bodies (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 17

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

OUTRAS DOENÇAS (4)
Joubert syndrome 17orofaciodigital syndrome type 6Joubert syndromemonomelic amyotrophy
HGNC:25801UniProt:Q9H799

Medicamentos e terapias

EPOPROSTENOLPhase 3

Mecanismo: Prostanoid IP receptor agonist

PRAVASTATINPhase 3

Mecanismo: HMG-CoA reductase inhibitor

IRBESARTANPhase 3

Mecanismo: Type-1 angiotensin II receptor antagonist

AMINOCAPROIC ACIDPhase 2

Mecanismo: Tissue-type plasminogen activator inhibitor

VALPROIC ACIDPhase 2

Mecanismo: Succinate semialdehyde dehydrogenase inhibitor

RITUXIMABPhase 2

Mecanismo: B-lymphocyte antigen CD20 binding agent

VALPROATE SODIUMPhase 2

Mecanismo: Succinate semialdehyde dehydrogenase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

595 variantes patogênicas registradas no ClinVar.

🧬 IL11RA: GRCh38/hg38 9p24.3-q21.13(chr9:208455-72054336)x3 ()
🧬 IL11RA: GRCh38/hg38 9p24.3-13.1(chr9:208455-38787483)x3 ()
🧬 IL11RA: NM_001142784.3(IL11RA):c.799G>A (p.Ala267Thr) ()
🧬 IL11RA: NM_001142784.3(IL11RA):c.838A>G (p.Ile280Val) ()
🧬 IL11RA: NM_001142784.3(IL11RA):c.806C>T (p.Ser269Phe) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 958 variantes classificadas pelo ClinVar.

144
144
670
Patogênica (15.0%)
VUS (15.0%)
Benigna (69.9%)
VARIANTES MAIS SIGNIFICATIVAS
POLR1A: NM_015425.6(POLR1A):c.2164C>T (p.Arg722Ter) [Likely pathogenic]
RUNX2: NM_001024630.4(RUNX2):c.859_859+1insACTCT [Pathogenic]
EFTUD2: NM_004247.4(EFTUD2):c.2499del (p.Phe833fs) [Pathogenic]
LFNG: NM_001040167.2(LFNG):c.1052C>T (p.Ser351Leu) [Uncertain significance]
LFNG: NM_001040167.2(LFNG):c.241C>T (p.Leu81Phe) [Uncertain significance]

Vias biológicas (Reactome)

211 vias biológicas associadas aos genes desta condição.

IL-6-type cytokine receptor ligand interactions POLR1D POLR1D Assembly of RNA Polymerase I Holoenzyme (human) Activation of NF-kappaB in B cells Prolactin receptor signaling SCF-beta-TrCP mediated degradation of Emi1 Vpu mediated degradation of CD4 Degradation of beta-catenin by the destruction complex Downstream TCR signaling Regulation of PLK1 Activity at G2/M Transition FCERI mediated NF-kB activation Deactivation of the beta-catenin transactivating complex Dectin-1 mediated noncanonical NF-kB signaling CLEC7A (Dectin-1) signaling Degradation of GLI1 by the proteasome Degradation of GLI2 by the proteasome GLI3 is processed to GLI3R by the proteasome NIK-->noncanonical NF-kB signaling MAP3K8 (TPL2)-dependent MAPK1/3 activation Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A Neddylation Interleukin-1 signaling GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 Antigen processing: Ubiquitination & Proteasome degradation GSK3B-mediated proteasomal degradation of PD-L1(CD274) Degradation of CRY and PER proteins Regulation of FZD by ubiquitination Association of TriC/CCT with target proteins during biosynthesis Myogenesis RUNX1 regulates transcription of genes involved in differentiation of HSCs NGF-stimulated transcription Negative Regulation of CDH1 Gene Transcription TGFBR3 expression Signaling by BMP Downregulation of SMAD2/3:SMAD4 transcriptional activity EGFR downregulation Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Formation of paraxial mesoderm Somitogenesis Formation of the posterior neural plate Meiotic synapsis Nuclear Envelope Breakdown Initiation of Nuclear Envelope (NE) Reformation Breakdown of the nuclear lamina XBP1(S) activates chaperone genes Depolymerization of the Nuclear Lamina Signaling by BRAF and RAF1 fusions Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models Peptide ligand-binding receptors G alpha (q) signalling events Hedgehog 'off' state Intraflagellar transport Adherens junctions interactions RAB34 GGC-RAB34 WNT ligand biogenesis and trafficking Class B/2 (Secretin family receptors) Transcriptional regulation of white adipocyte differentiation PI3K Cascade PIP3 activates AKT signaling FGFR2c ligand binding and activation FGFR2b ligand binding and activation Signaling by FGFR2 amplification mutants Activated point mutants of FGFR2 Constitutive Signaling by Aberrant PI3K in Cancer Phospholipase C-mediated cascade; FGFR2 PI-3K cascade:FGFR2 SHC-mediated cascade:FGFR2 FRS-mediated FGFR2 signaling Negative regulation of FGFR2 signaling Signaling by FGFR2 in disease RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Signaling by FGFR2 IIIa TM Signaling by FGFR2 fusions Signaling by FGFR1 amplification mutants Signaling by activated point mutants of FGFR1 FGFR1b ligand binding and activation FGFR1c ligand binding and activation FGFR1c and Klotho ligand binding and activation NCAM signaling for neurite out-growth Signal transduction by L1 Phospholipase C-mediated cascade: FGFR1 Downstream signaling of activated FGFR1 SHC-mediated cascade:FGFR1 PI-3K cascade:FGFR1 FRS-mediated FGFR1 signaling Negative regulation of FGFR1 signaling Signaling by FGFR1 in disease Signaling by plasma membrane FGFR1 fusions Epithelial-Mesenchymal Transition (EMT) during gastrulation G alpha (s) signalling events mRNA Splicing - Major Pathway mRNA Splicing - Minor Pathway Dengue Virus-Host Interactions Hedgehog 'on' state GLI proteins bind promoters of Hh responsive genes to promote transcription RUNX2 regulates osteoblast differentiation Signaling by activated point mutants of FGFR3 FGFR4 ligand binding and activation FGFR3b ligand binding and activation FGFR3c ligand binding and activation Phospholipase C-mediated cascade; FGFR3 Phospholipase C-mediated cascade; FGFR4 SHC-mediated cascade:FGFR3 FRS-mediated FGFR3 signaling PI-3K cascade:FGFR3 FRS-mediated FGFR4 signaling SHC-mediated cascade:FGFR4 PI-3K cascade:FGFR4 Transport of Mature mRNA derived from an Intron-Containing Transcript mRNA 3'-end processing RNA Polymerase II Transcription Termination Regulation of expression of SLITs and ROBOs Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) HATs acetylate histones Pyrimidine biosynthesis Formation of the ureteric bud Activation of PUMA and translocation to mitochondria Pyroptosis TP53 Regulates Metabolic Genes TP53 Regulates Transcription of Genes Involved in Cytochrome C Release TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain TP53 Regulates Transcription of Caspase Activators and Caspases TP53 Regulates Transcription of Death Receptors and Ligands Regulation of TP53 Activity through Association with Co-factors Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin Developmental Lineage of Mammary Gland Luminal Epithelial Cells Developmental Lineage of Mammary Gland Myoepithelial Cells Developmental Lineage of Mammary Stem Cells POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation Transcriptional regulation of pluripotent stem cells Regulation of PTEN gene transcription Regulation of gene expression by Hypoxia-inducible Factor BMAL1:CLOCK,NPAS2 activates circadian expression Pre-NOTCH Transcription and Translation PPARA activates gene expression Formation of the beta-catenin:TCF transactivating complex Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells NOTCH1 Intracellular Domain Regulates Transcription Transcriptional activation of mitochondrial biogenesis Activation of gene expression by SREBF (SREBP) Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production Attenuation phase Notch-HLH transcription pathway SUMOylation of transcription cofactors Regulation of lipid metabolism by PPARalpha Activation of anterior HOX genes in hindbrain development during early embryogenesis CD209 (DC-SIGN) signaling Activation of the TFAP2 (AP-2) family of transcription factors RUNX1 regulates transcription of genes involved in differentiation of myeloid cells RUNX3 regulates NOTCH signaling NOTCH3 Intracellular Domain Regulates Transcription NOTCH4 Intracellular Domain Regulates Transcription Estrogen-dependent gene expression TRAF3-dependent IRF activation pathway TRAF6 mediated IRF7 activation FOXO-mediated transcription of cell death genes RIF1 and PAX1IP bind TP53BP1 at DNA DSBs DNA DNA DSBs:p-MRN:p-S1981,Ac-K3016-ATM:KAT5:K63PolyUb-K14,K16,p-S139-H2AFX,Me2K21-HIST1H4A-Nucleosome:p-5T-MDC1:p-S102-WHSC1:RNF8:Zn2+:SUMO1:p-T4827-HERC2:UBE2N:UBE2V2:RNF168:PIAS4:p-S25,S1778-TP53BP1:RIF1:PAX1IP:DCLRE1C Anchoring of the basal body to the plasma membrane mRNA Polyadenylation YAP1- and WWTR1 (TAZ)-stimulated gene expression Physiological factors Cardiogenesis Regulation of RUNX2 expression and activity Specification of the neural plate border t(4;14) translocations of FGFR3 Negative regulation of FGFR3 signaling Signaling by FGFR3 in disease Signaling by FGFR3 fusions in cancer Hedgehog ligand biogenesis Hh mutants are degraded by ERAD Release of Hh-Np from the secreting cell Ligand-receptor interactions Activation of SMO HHAT G278V doesn't palmitoylate Hh-Np Formation of lateral plate mesoderm Formation of axial mesoderm Developmental Lineage of Multipotent Pancreatic Progenitor Cells Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Impaired BRCA2 binding to SEM1 (DSS1) Diseases of DNA Double-Strand Break Repair Molecules associated with elastic fibres Pre-NOTCH Processing in Golgi Defective LFNG causes SCDO3 Nephron development Transcriptional and post-translational regulation of MITF-M expression and activity RNU12 gene U12 snRNA U1,U2,U4,U4atac,U5,U11,U12 gene RUNX2 regulates chondrocyte maturation PKA activation PKA activation in glucagon signalling DARPP-32 events Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Vasopressin regulates renal water homeostasis via Aquaporins CREB1 phosphorylation through the activation of Adenylate Cyclase GPER1 signaling ADORA2B mediated anti-inflammatory cytokines production FCGR3A-mediated IL10 synthesis ALK mutants bind TKIs Signaling by ALK fusions and activated point mutants Factors involved in megakaryocyte development and platelet production High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells PKMTs methylate histone lysines Formation of the nephric duct

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 33
2Fase 24
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 7 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Disostose

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
494 papers (10 anos)
#1

The Diagnostic Odyssey of a Biochemically Confirmed Case of ML II: The First Western Patient With LYSET Deficiency.

Clinical genetics2026 Mar 20

The LYSET gene encodes the LYSET transmembrane protein, which regulates lysosome biogenesis by activating the mannose-6-phosphate (M6P) pathway. This is an autosomal recessive, ultrarare, and severe progressive skeletal dysplasia with coarse facies, distended abdomen, short stature, and severe physical disability. In a diagnostic odyssey, we report a female patient, born in 2008, daughter of consanguineous parents, with hand contractures and a typical facial appearance since 5 months old. She was clinically diagnosed at 2 years old with contractures and severe dysplasia. Systolic murmur, thickening of mitral and aortic valves, and tricuspid regurgitation were observed. Nine enzymes showed increased levels in plasma, and seven showed decreased levels in fibroblasts. Abnormal sialic acid profile and GAGs (glycosaminoglycans) were detected in urine. No variants were identified during more than a decade of investigation. A whole-genome analysis identified the homozygous nonsense variant NM_001098621.4:c.112C>T (p.Gln38Ter) in the LYSET gene. The patient had not been diagnosed before due to the recent association of the gene with the lysosomal hydrolase labeling pathway. She died in 2018 from respiratory causes. The discovery of the relationship between the LYSET gene and lysosomal biogenesis was determinative of the diagnostic conclusion. Cases of dysostosis multiplex can be highly challenging due to the rarity of the disease and its clinical similarity to mucopolysaccharidosis (MPS) and mucolipidosis II/III (MLII/III). This is the first western report of a challenging case of an extensive diagnostic odyssey and demonstrates that the LYSET gene must be considered in the differential diagnosis when M6P-labeled lysosomal enzymes are altered.

#2

Genetic and Molecular Characterization of Treacher Collins Syndrome in Three Mexican Families.

International journal of molecular sciences2026 Feb 16

Treacher Collins syndrome (TCS) is a rare disorder within the group of mandibulofacial dysostoses, occurring in 1 in 50,000 live births. It is characterized by anomalies in the maxillary, mandibular, and stapes bones, among others. TCS is caused by pathogenic variants in the TCOF1, POLR1D, POLR1C, and POLR1B genes with autosomal dominant or recessive inheritance patterns. Genetic data from Latin American populations remain scarce. Eleven patients from three different families were recruited. Whole-exome sequencing (WES) was performed on the probands to identify genetic variants, followed by Sanger sequencing for variant validation and familial segregation analysis. Finally, three-dimensional protein structures of wild-type and mutant proteins were predicted. In Family 1, a heterozygous pathogenic splice-site variant in the TCOF1 gene, c.4345 + 1 G > A, was identified and inherited from her mother. In Family 2, a heterozygous pathogenic variant in the TCOF1 gene, c.226_227insC (p.R77fs), was identified and inherited from the paternal lineage. In Family 3, a heterozygous pathogenic POLR1D variant, c.290_291delAG (p.G99fs), was identified among multiple affected relatives; direct parent-of-origin could not be established due to unavailability of one parent, but segregation supports autosomal dominant transmission across three generations. All findings were validated by Sanger sequencing. Our findings highlight the utility of WES for the molecular diagnosis of TCS and underscore the importance of including underrepresented populations in genetic studies to improve diagnosis, genetic counseling, and perinatal planning in at-risk pregnancies.

#3

The Phenotypic Spectrum of Miller Syndrome: Insight From a French Cohort.

Clinical genetics2026 Jan

Miller syndrome (MIM#263750) is a rare autosomal recessive acrofacial dysostosis associated with biallelic DHODH variants. Since the identification of the gene in 2010, five case reports have described a variable phenotype in only nine individuals from eight families. We present a cohort of 10 individuals from seven families affected by Miller syndrome, spanning the prenatal stage to 46 years of age. We report on the largest cohort of Miller syndrome to date, which highlights novel findings, including optic atrophy in multiple members of one consanguineous family. The typical postaxial limb defects, including the absence of the 5th digit, were consistent with prior descriptions, but we highlighted the frequent involvement of preaxial structures (thumb and tibial hypoplasia). A higher incidence of camptodactyly and the presence of facial nevus in two patients were notable findings. Congenital heart defects, primarily atrial septal defects, were common, and all living individuals had normal neurodevelopment. This cohort expands the phenotypic spectrum of Miller syndrome associated with variation in DHODH, presenting new findings such as preaxial involvement and facial nevus simplex. Optic atrophy in one family could prompt screening of other cases. Early prenatal diagnosis, particularly in the presence of cardinal limb and cardiac malformations, is crucial for management and genetic counseling. Mucopolysaccharidosis type I (MPS I) is a progressive multisystem disorder with features ranging over a continuum of severity. While affected individuals have traditionally been classified as having one of three MPS I syndromes (Hurler syndrome, Hurler-Scheie syndrome, or Scheie syndrome), no easily measurable biochemical differences have been identified and the clinical findings overlap. Affected individuals are best described as having either a phenotype consistent with either severe (Hurler syndrome) or attenuated MPS I, a distinction that influences therapeutic options. Severe MPS I: Infants appear normal at birth. Typical early manifestations are nonspecific (e.g., umbilical or inguinal hernia, frequent upper respiratory tract infections before age 1 year). Coarsening of the facial features may not become apparent until after age one year. Gibbus deformity of the lower spine is common and often noted within the first year. Progressive skeletal dysplasia (dysostosis multiplex) involving all bones is universal, as is progressive arthropathy involving most joints. By age three years, linear growth decreases. Intellectual disability is progressive and profound but may not be readily apparent in the first year of life. Progressive cardiorespiratory involvement, hearing loss, and corneal clouding are common. Without treatment, death (typically from cardiorespiratory failure) usually occurs within the first ten years of life. Attenuated MPS I: Clinical onset is usually between ages three and ten years. The severity and rate of disease progression range from serious life-threatening complications leading to death in the second to third decade, to a normal life span complicated by significant disability from progressive joint manifestations and cardiorespiratory disease. While some individuals have no neurologic involvement and psychomotor development may be normal in early childhood, learning disabilities and psychiatric manifestations can be present later in life. Hearing loss, cardiac valvular disease, respiratory involvement, and corneal clouding are common. The diagnosis of MPS I is established in a proband with suggestive clinical and laboratory findings by: detection of deficient activity of the lysosomal enzyme α-L-iduronidase (IDUA) in combination with elevation of glycosaminoglycan levels; and/or identification of biallelic pathogenic variants in IDUA on molecular genetic testing. Identification of the causative IDUA variants plays an important role in the determination of phenotype. Treatment of manifestations: An essential component of management is the determination of whether the proband has severe or attenuated MPS I. This requires detailed clinical and laboratory assessment and can be challenging in very young individuals. Targeted therapies: Hematopoietic stem cell transplantation (HSCT) is considered the standard of care for children with severe MPS I. Outcome is significantly influenced by disease burden at the time of diagnosis (and thus, by the age of the individual). HSCT can improve cognitive outcomes, increase survival, improve growth, reduce facial coarseness and hepatosplenomegaly, improve hearing, prevent hydrocephalus, and alter the natural history of cardiac and respiratory symptomatology. HSCT has lesser effects on the skeletal and joint manifestations, corneal clouding, and cardiac involvement. HSCT alters the course of cognitive decline in children with severe MPS I; cognitive outcome is greatly influenced by the degree of cognitive impairment at the time of transplantation. Due to the morbidity and mortality associated with HSCT, it is currently recommended primarily for children with severe MPS I. Enzyme replacement therapy (ERT) with laronidase (Aldurazyme®), licensed for treatment of the non-CNS manifestations of MPS I, improves liver size, linear growth, and mobility and joint range of motion; slows progression of respiratory disease; and improves sleep apnea in persons with attenuated disease. The age of initiation of ERT influences the outcome. Supportive care: Infant learning programs/special education for developmental delay; physical therapy, orthopedic surgery as needed, joint replacement for progressive arthropathy, atlanto-occipital stabilization; spinal cord decompression for cervical myelopathy; cerebrospinal fluid shunting for hydrocephalus; early median nerve decompression for carpal tunnel syndrome based on nerve conduction studies before clinical manifestations develop; special attention to anesthetic risks; hats with visors/sunglasses to reduce glare, corneal transplantation for ophthalmologic involvement; cardiac valve replacement as needed and bacterial endocarditis prophylaxis for those with cardiac involvement; tonsillectomy and adenoidectomy for eustachian tube dysfunction and/or upper airway obstruction; ventilating tubes; hearing aids as needed; CPAP for sleep apnea; gastrointestinal management for diarrhea and constipation. Surveillance: Annual assessment by a team of physicians with knowledge of the multisystem nature of MPS I. Specialists and assessments: orthopedic surgery including annual assessment of median nerve conduction velocity; ophthalmology, cardiology (including echocardiography), respiratory with assessment of pulmonary function and sleep studies, audiology, and otolaryngology. Assessment for constipation and/or hernias as needed. Early and continuous monitoring of head growth in infants and children with imaging as needed; assessment for evidence of spinal cord compression by neurologic examination; developmental assessment annually; and psycho-educational assessment of children with attenuated disease prior to primary school entry. Evaluation of relatives at risk: Early diagnosis prior to significant disease manifestations is warranted in relatives at risk in order to initiate therapy as early in the course of disease as possible. MPS I is inherited in an autosomal recessive manner. At conception, each child of a couple in which both parents are heterozygous for a IDUA pathogenic variant has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if both disease-causing IDUA variants have been identified in the family.

#4

Evaluation of a Facial Dysmorphology Analysis Algorithm (Face2Gene) in Identifying Treacher Collins Syndrome Amongst Diverse Population.

Orthodontics & craniofacial research2026 Mar 12

Treacher Collins Syndrome (TCS) is an uncommon congenital disease of the craniofacial complex. While there are 'classic' facial manifestations of TCS, they present with a wide range of variability. Face2Gene (F2G) is a deep-learning algorithm that can provide differential diagnoses of syndromes via analysis of 2-dimensional facial images. This may aid early recognition of TCS, thus improving early multidisciplinary management. Our primary aim is to evaluate and compare the performance of F2G in TCS patients of various races. The secondary aim will be to correlate the pathognomonic facial features of these TCS patients with the diagnostic stratification by F2G. Publicly available images of TCS patients of White (n = 81), Chinese (n = 23), and Indian (n = 23) race were sourced for and screened prior to inclusion for documentation of facial dysmorphological features and F2G evaluation. The diagnostic sensitivity of F2G and computed gestalt score of TCS for each image were then derived. Statistical analysis for correlation between clinical features and F2G-derived gestalt scores for the TCS patients was performed. A total of 127 images of TCS patients were analysed by F2G. A high diagnostic accuracy of 93.7% was obtained. However, F2G was less confident when diagnosing Asians with TCS than White individuals (p < 0.05). Malar hypoplasia was less prevalent in Indian TCS patients (p < 0.001). However, multidimensionality reduction showed no significant differences across the racial groups. Certain facial features were associated with higher model certainty in TCS diagnosis. F2G is a useful diagnostic adjunct for TCS. Nonetheless, further training on non-White datasets may help improve model certainty in diagnosis.

#5

Lamb-Shaffer syndrome in a Chinese adolescent: A case report.

Medicine2026 Mar 06

Lamb-Shaffer syndrome (LAMSHF) is a rare neurodevelopmental disorder caused by pathogenic variants in the SRY-related high-mobility group box 5 (SOX5) gene. Clinical features are heterogeneous, and novel variants continue to be reported, expanding the genotypic and phenotypic spectrum of the disease. A 15-year-old male presented with short stature, mild intellectual disability, epilepsy, and multiple congenital anomalies, including facial dysmorphism and right thumb syndactyly. Whole-exome sequencing identified a novel heterozygous variant in the SOX5 gene, c.1160G>A (p.Ser387Asn), located at 12p12.1. Although initially classified as a variant of uncertain significance according to ACMG criteria, its strong correlation with the clinical phenotype supported the diagnosis of LAMSHF. The patient has been maintained on levetiracetam for epilepsy management and is receiving dental care for maxillofacial deformities. A multidisciplinary rehabilitation approach is recommended. Seizures are well-controlled with no recurrence. The patient demonstrates stable cognitive and functional status under current supportive care. This case reports a novel SOX5 variant associated with LAMSHF and highlights the importance of genetic confirmation in patients with unexplained neurodevelopmental features to guide appropriate management and avoid unnecessary interventions.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.608 artigos no totalmostrando 198

2026

The Diagnostic Odyssey of a Biochemically Confirmed Case of ML II: The First Western Patient With LYSET Deficiency.

Clinical genetics
2026

Evaluation of a Facial Dysmorphology Analysis Algorithm (Face2Gene) in Identifying Treacher Collins Syndrome Amongst Diverse Population.

Orthodontics &amp; craniofacial research
2026

Lamb-Shaffer syndrome in a Chinese adolescent: A case report.

Medicine
2026

Congenital Temporomandibular Joint Ankylosis: Investigating Potential Genetic Etiologies with Whole Exome Sequencing.

Journal of clinical medicine
2026

Genetic and Molecular Characterization of Treacher Collins Syndrome in Three Mexican Families.

International journal of molecular sciences
2026

A Splice Acceptor Variant in DLL3 Is Associated with Spondylocostal Dysostosis in a Litter of Mixed-Breed Dogs.

Genes
2026

A Novel Association Between Mandibulofacial Dysostosis with Microcephaly and Congenital Diaphragmatic Hernia.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2026

Nager Syndrome Revisited: Integrating In Vivo and In Vitro Models to Decipher SF3B4-Dependent Tissue Coordination.

WIREs mechanisms of disease
2026

A novel EVC2 splice-site variant expands the mutational and phenotypic spectrum of Weyers acrofacial dysostosis.

BMC medical genomics
2025

Novel FUCA1 variants in two families, including the first report of a contiguous gene deletion syndrome involving FUCA1 and HMGCL.

The Turkish journal of pediatrics
2026

Unveiling alpha-mannosidosis in Iraqi children: A series of clinically and genetically characterized cases with novel MAN2B1 variant.

Molecular genetics and metabolism reports
2026

Analysis of Treacher Collins syndrome 4-associated mutations in Schizosaccharomyces pombe.

FEBS open bio
2026

Spondylocostal Dysostosis-1 Associated With Pancreatic Heterotopia: Coincidence or True Association?

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2026

Recurrent mandibulofacial dysostosis, Guion-Almeida type in consecutive pregnancies due to maternal mosaicism of a novel EFTUD2 variant: a case report and review of the literature.

Journal of medical case reports
2025

Freeman-Sheldon Syndrome: A Rare Case Report with Dental Perspective.

Prague medical report
2025

A novel pathogenic variant in POLR1D (c.220dup, p.His74ProfsTer8) causes Treacher Collins syndrome type 2 in a Chinese patient: a case report.

BMC pediatrics
2025

Phenotypic Divergence in Siblings with the Same Genotype: Diffuse Dermal Melanocytosis in Infantile-Onset Galactosialidosis.

Molecular syndromology
2025

A New Case of Nager Syndrome as a Rare Cause of Acrofacial Dysostosis.

Molecular syndromology
2026

The Phenotypic Spectrum of Miller Syndrome: Insight From a French Cohort.

Clinical genetics
2025

Clinical and Radiological Spectrum in Cleidocranial Dysplasia: A Case Series.

Current health sciences journal
2026

Analysis of the Learning Curve for a Surgeon Newly Trained in Frontofacial Monobloc Advancement.

The Journal of craniofacial surgery
2025

Whole-Exome Sequencing Revealed a Novel De Novo Pathogenic EFTUD2 Variant in Mandibulofacial Dysostosis, Guion-Almeida Type: Reinforcing Links to Choanal and Oesophageal Atresia.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2026

Prevalence and Patterns of Permanent Tooth Agenesis in Patients With Crouzon or Apert Syndrome: A Systematic Review and Meta-Analysis.

Orthodontics &amp; craniofacial research
2025

Modeling craniofacial spliceosomopathies: a pathway toward deciphering disease mechanisms.

Frontiers in cell and developmental biology
2026

Contributing Factors for Angle's Class III Phenotype in Crouzon Syndrome.

European journal of paediatric dentistry
2026

Long-read DNA and RNA sequencing reveal an intronic retrotransposon insertion in TCOF1 causing Treacher Collins syndrome.

HGG advances
2026

A Confirmatory Case of Severe Spondylocostal Dysostosis Caused by Biallelic Loss-of-Function of DMRT2.

American journal of medical genetics. Part A
2025

RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.

Genes
2025

Evaluation of masticatory function in the pediatric and adult populations with Treacher Collins syndrome.

Journal of oral biology and craniofacial research
2025

Unusual Bone Abnormalities in a Girl With Spondylocostal Dysostosis.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2025

Neurodevelopmental trajectories and mis-splicing in Chinese patients caused by novel EFTUD2 mutations.

Gene
2025

Novel Phenotypic Insights into the IDS c.817C>T Variant in Mucopolysaccharidosis Type II from Newborn Screening Cohorts.

International journal of neonatal screening
2025

Low-Density Instrumentation for Scoliosis Correction in Monozygotic Twins With Treacher Collins Syndrome: A Case Report.

JBJS case connector
2025

Use of cartilage-conduction hearing aids in a child with Crouzon syndrome and meatal atresia.

Auris, nasus, larynx
2025

Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I.

Molecular therapy. Methods &amp; clinical development
2025

PTBP3 Associated With 9q32 Locus Is a Candidate Gene for Nager Syndrome.

Birth defects research
2025

Facial Bone Defects Associated with Lateral Facial Clefts Tessier Type 6, 7 and 8 in Syndromic Neurocristopathies: A Detailed Micro-CT Analysis on Historical Museum Specimens.

Biology
2025

Gene-environment interactions modulate the phenotype severity in mouse models of congenital craniofacial syndromes.

The Journal of clinical investigation
2025

The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach.

The Journal of craniofacial surgery
2025

A novel EFTUD2 splicing variant causing mandibulofacial dysostosis with microcephaly: a case report.

Translational pediatrics
2025

In silico analysis identified potential interaction between glutathione and spliceosome in Nager Syndrome.

Free radical biology &amp; medicine
2025

Spondylocostal dysostosis with split cord malformation in a resource-limited setting: A case report.

Radiology case reports
2025

Novel Splice Variant in the HES7 Gene in Vietnamese Patient with Spondylocostal Dysostosis 4: A Case Report and Literature Review.

Diagnostics (Basel, Switzerland)
2025

Differential impact of Crouzon and Apert syndromes on upper airways morphology: implications for Obstructive Sleep Apnoea.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2026

The influence of closed sutures on cranial morphology in Apert and Crouzon syndromes: A quantitative analysis.

Journal of anatomy
2025

Clarifying the Relationship Between Orbito-Zygomatic and Mandibular Dysmorphology in Treacher Collins Syndrome.

The Journal of craniofacial surgery
2025

Facial asymmetry in syndromic craniosynostosis patients undergoing midface surgery compared to a large general population.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2025

EFTUD2 Regulates Cortical Morphogenesis via Modulation of Caspase-3 and Aifm1 Splicing Pathways.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Addressing the Diagnostic Odyssey for Adults With Neurodevelopmental Disabilities: Case Study of an Individual With Mandibulofacial Dysostosis With Microcephaly.

American journal of medical genetics. Part A
2025

Regional variability in craniofacial stiffness: a study in normal and Crouzon mice during postnatal development.

Biomechanics and modeling in mechanobiology
2025

Mucopolysaccharidosis type IVA (Morquio A) in twins masquerading as distal renal tubular acidosis.

BMJ case reports
2025

Novel nonsense mutation in the TCOF1 gene associated with treacher collins syndrome: A case report.

Science progress
2025

Unveiling the Phenotypic Spectrum of Miller Syndrome: A Systematic Review.

The Journal of craniofacial surgery
2025

Fathoming the scientific paradox of intangibles: protocol reappraisal for optimizing cognitive outcomes in faciocraniosynostosis-an institutional experience.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Management and Outcomes of Neonates with Treacher Collins and Nager Syndromes.

The Journal of pediatrics
2025

Identification of novel TCOF1 mutations in Treacher Collins syndrome and their functional characterization.

Orphanet journal of rare diseases
2025

Sialocele formation following facial reconstruction in a patient with Treacher Collins Syndrome.

Orbit (Amsterdam, Netherlands)
2025

Clinical and genetic spectrums of Mucopolysaccharidosis type IV in Duhok city, Kurdistan region, Iraq.

Cellular and molecular biology (Noisy-le-Grand, France)
2025

Current Understanding of Crouzon Syndrome Pathophysiology and New Therapeutic Approaches.

The Journal of craniofacial surgery
2025

Upper Airway Obstruction Trends in Craniofacial Syndromes: A Comparative Study.

The Journal of craniofacial surgery
2025

Epidural analgesia for a successful vaginal delivery in a parturient with Jarcho-Levin syndrome: case report.

BMC anesthesiology
2025

Biallelic Variant in LYSET Associated With Mucolipidosis II-Like Phenotype.

American journal of medical genetics. Part A
2025

Strategies for Improving Case Reports Involving Patients With Rare Diseases.

Cureus
2025

Spondylocostal dysostosis: A rare and remarkable syndrome.

Radiology case reports
2025

Clinical Nasal Deviation Following Midface Advancement in Patients With Syndromic Craniosynostosis.

The Journal of craniofacial surgery
2025

Deletion of sf3b4 causes splicing defects and gene dysregulation that disrupt craniofacial development and survival.

Disease models &amp; mechanisms
2025

Spliceosome protein EFTUD2: A potential pathogenetic factor in tumorigenesis and some developmental defects (Review).

Molecular medicine reports
2025

The cranial base and midface characteristics in apert and Crouzon syndrome: A 3-dimensional analysis of morphological variations.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2025

Human stem cell model of neural crest cell differentiation reveals a requirement of SF3B4 in survival, maintenance, and differentiation.

Developmental dynamics : an official publication of the American Association of Anatomists
2025

[Perioperative management of cochlear implantation and analysis on the influencing factors of efficacy in patients diagnosed as hereditary syndromic hearing loss].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
2025

Postnatal Progressive Craniosynostosis: An Unusual Case Presentation Leading to Cascade Diagnosis for Multiple Generations.

American journal of medical genetics. Part A
2025

Structural and functional stenosis of the upper airway in Crouzon syndrome patients: A computational fluid dynamics analysis.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2025

Prevalence and treatment outcomes of hydrocephalus among children with craniofacial syndromes.

Journal of plastic surgery and hand surgery
2025

Deciphering TCOF1 mutations in Chinese Treacher Collins syndrome patients: insights into pathogenesis and transcriptional disruption.

Orphanet journal of rare diseases
2025

Highlighting the importance of X-ray diagnostics for targeted molecular genetic analysis in the diagnosis of rare autosomal dominant craniometaphyseal dysplasia.

BMJ case reports
2025

Long-term outcomes of enzyme replacement therapy from a large cohort of Korean patients with mucopolysaccharidosis IVA (Morquio A syndrome).

Molecular genetics and metabolism reports
2025

Spectrum of Otological Manifestations in Treacher Collins Syndrome: A Case Series of 9 Patients.

Journal of computer assisted tomography
2024

Detection of inversion with breakpoints in ARSB causing MPS VI by whole-genome sequencing: lessons learned and best practices.

Frontiers in genetics
2025

Bone-Specific Manifestations of Spondylothoracic Dysostosis in Jarcho-Levin Syndrome.

American journal of respiratory and critical care medicine
2025

A rare case of acrodysostosis type 2 with PDE4D mutation in a young female: a case report.

Oxford medical case reports
2025

Fucosidosis: A Review of a Rare Disease.

International journal of molecular sciences
2025

Simultaneous Lefort 2 Distraction and Fronto-Orbito-Malar Advancement: Correcting Severe Upper and Midface Retrusion in a Patient With Crouzon Syndrome.

The Journal of craniofacial surgery
2024

Anesthesia for Cesarean Delivery in a Patient With Spondylocostal Dysostosis: A Case Report.

A&amp;A practice
2024

Bilevel positive airway pressure treatment of sleep apnea syndrome in a patient with Crouzon syndrome.

Sleep &amp; breathing = Schlaf &amp; Atmung
2024

Molecular analysis of mucopolysaccharidosis type VI in Iranian patients; the influence of founder effect and consanguinity.

Molecular biology reports
2025

Imaging of Treacher Collins syndrome: A case report.

Radiology case reports
2024

Molecular and Clinical Heterogeneity in Hungarian Patients with Treacher Collins Syndrome-Identification of Two Novel Mutations by Next-Generation Sequencing.

International journal of molecular sciences
2024

Most common congenital syndromes with facial asymmetry: A narrative review.

Dental and medical problems
2024

Anomalous venous collaterals in Apert and Crouzon syndromes and their relationship to ventricle size and increased intracranial pressure.

Journal of neurosurgery. Pediatrics
2024

A mild skeletal phenotype with overlapping features of Miller syndrome and functional characterisation of two new variants of human dihydroorotate dehydrogenase.

Heliyon
2024

Clinical report of metacarpal melorheostosis: a rare disease with "the dripping candle wax" appearance on different imaging modalities.

Oxford medical case reports
2024

Intracranial tumor in a patient with mucopolysaccharidosis type 1 (Scheie syndrome): An extremely rare combination.

Heliyon
2024

Congenital Pseudoarthrosis of the Femur Managed with Masquelet Technique.

Journal of orthopaedic case reports
2024

The diagnosis and management of mucopolysaccharidosis type II.

Italian journal of pediatrics
2025

Severe Phenotype With RECQL4 Syndrome: A Report of Two Cases.

American journal of medical genetics. Part A
2025

Casamassima-Morton-Nance Syndrome and Limb-Body Wall Defect: Presentation of the Second Case and Phenotypic Assessment.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2024

Reducing the risk of unfavourable fractures in Le Fort III osteotomy via a navigation-guided technique.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2024

[Treacher Collins Syndrome 2 caused by a novel pathogenic variant in PLOR1D: clinical report and literature review].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
2025

Frontal Bone Resorption after Frontofacial Monobloc Advancement in FGFR -Related Craniosynostoses: Predictive Factors.

Plastic and reconstructive surgery
2024

The First Patient with Tibial Hemimelia-Polysyndactyly-Triphalangeal Thumb Syndrome Caused by De Novo c.423+4916 T>C ZRS Variant: A Case Report.

International journal of molecular sciences
2024

Untangling Zebrafish Genetic Annotation: Addressing Complexities and Nomenclature Issues in Orthologous Evaluation of TCOF1 and NOLC1.

Journal of molecular evolution
2024

RPL26 variants: A rare cause of Diamond-Blackfan anemia syndrome with multiple congenital anomalies at the forefront.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Mixed reality guided advancement osteotomies in congenital craniofacial malformations.

Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS
2024

Dual diagnosis of achondroplasia and mandibulofacial dysostosis with microcephaly.

BMC medical genomics
2025

Compound heterozygosity for two variants in BMP5 in human skeletal dysostosis with atrioventricular septal defect.

Clinical genetics
2024

Ocular manifestations and treatment progress of Crouzon syndrome.

International ophthalmology
2025

Using a Disentangled Neural Network to Objectively Assess the Outcomes of Midfacial Surgery in Syndromic Craniosynostosis.

Plastic and reconstructive surgery
2024

Optic canal stenosis in Crouzon syndrome: a case report and literature review.

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2024

New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities.

Journal of molecular medicine (Berlin, Germany)
2024

Spliceosomal GTPase Eftud2 deficiency-triggered ferroptosis leads to Purkinje cell degeneration.

Neuron
2024

Biobank for craniosynostosis and faciocraniosynostosis, rare pediatric congenital craniofacial disorders: a study protocol.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis.

Journal of anatomy
2024

Optic nerve elongation during fronto-facial surgery for Crouzon syndrome: 3D quantification and clinical implications.

Journal of neurosurgery. Pediatrics
2024

Radiological Diagnosis of Crouzon Syndrome: A Case Study.

Cureus
2024

Prenatal diagnosis of SLC25A24 Fontaine progeroid syndrome: description of the fetal phenotype, genotype and detection of parental mosaicism.

Birth defects research
2024

Integrative analysis of Lunatic Fringe variants associated with spondylocostal dysostosis type-III.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2024

Distractor position and distraction amplitude in fronto-facial monobloc advancement : A case series.

Journal of stomatology, oral and maxillofacial surgery
2024

Clinico-Radiological Perspectives of Pycnodysostosis - A Rare Case Series.

Journal of pharmacy &amp; bioallied sciences
2024

Spondylocostal dysostosis with type II split cord malformation: A report of a rare case and brief review of the literature.

Radiology case reports
2025

Periorbital Outcomes and Vision Risk Stratification in Treacher Collins Syndrome.

Plastic and reconstructive surgery
2024

Adenoidectomy in a child with Crouzon syndrome complicated with severe obstructive sleep apnea: Case report and review of literature.

Medicine
2024

Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts.

The Journal of craniofacial surgery
2024

Three-dimensional quantification of soft tissue changes and its relationship to skeletal changes after Le Fort III, monobloc, and facial bipartition in syndromic craniosynostosis.

International journal of oral and maxillofacial surgery
2024

Spondylothoracic Dysostosis: Crab-like Rib Cage Configuration in a Neonate with Jarcho-Levin Syndrome.

American journal of respiratory and critical care medicine
2024

Apert syndrome: neurosurgical outcomes and complications following posterior vault distraction osteogenesis.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Artificial intelligence-based diagnosis in fetal pathology using external ear shapes.

Prenatal diagnosis
2024

Further characterization of ARSK-related mucopolysaccharidosis type 10.

American journal of medical genetics. Part A
2024

Possible germline mosaicism in a pedigree with Treacher Collins syndrome: A case report and brief review.

Science progress
2024

Skeletal changes after midface surgery in patients with craniofacial deformities: a three-dimensional quantification method.

International journal of oral and maxillofacial surgery
2025

Thirty-Year Experience Treating Syndromic Craniosynostosis: Long-Term Outcomes following Cranial Expansions.

Plastic and reconstructive surgery
2024

Juvenile sialidosis: a rare case and review of the literature.

Annals of medicine and surgery (2012)
2024

Identification of a novel LFNG variant in a Chinese fetus with spondylocostal dysostosis and a systematic review.

Journal of human genetics
2024

Atypical mandibulofacial dysostosis with microcephaly diagnosed through the identification of a novel pathogenic mutation in EFTUD2.

Molecular genetics &amp; genomic medicine
2024

p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.

International journal of biological macromolecules
2024

The transcription of the main gene associated with Treacher-Collins syndrome (TCOF1) is regulated by G-quadruplexes and cellular nucleic acid binding protein (CNBP).

Scientific reports
2024

Variant characterisation and clinical profile in a large cohort of patients with Ellis-van Creveld syndrome and a family with Weyers acrofacial dysostosis.

Journal of medical genetics
2024

Transcriptomic analysis reveals mitochondrial dysfunction in the pathogenesis of Nager syndrome in sf3b4-depleted zebrafish.

Biochimica et biophysica acta. Molecular basis of disease
2024

Morquio B disease: a case report.

Frontiers in pediatrics
2024

A novel intronic TCOF1 pathogenic variant in a Chinese family with Treacher Collins syndrome.

BMC medical genomics
2024

Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells.

JCI insight
2024

[Diagnosis of a Chinese pedigree affected with Treacher-Collins syndrome due to a novel variant of TCOF1 gene through whole exome sequencing].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Two novel pathogenic variants in the TCOF1 found in two Chinese cases of Treacher Collins syndrome.

Molecular genetics &amp; genomic medicine
2024

Weyers Acrofacial Dysostosis: A Case Report.

Cureus
2025

Dosage-dependent effects of FGFR2W290R mutation on craniofacial shape and cellular dynamics of the basicranial synchondroses.

Anatomical record (Hoboken, N.J. : 2007)
2024

Association of cranial base suture/synchondrosis fusion with severity of increased intracranial pressure in Crouzon syndrome.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
2024

Early prenatal diagnosis of spondylocostal dysostosis caused by a novel variant in MESP2.

Congenital anomalies
2024

Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2024

Correlation analysis of airway-facial phenotype in Crouzon syndrome by geometric morphometrics: A promising method for non-radiation airway evaluation.

Orthodontics &amp; craniofacial research
2024

Molecular landscape of congenital vertebral malformations: recent discoveries and future directions.

Orphanet journal of rare diseases
2024

A European Multicenter Outcome Study of Perioperative Airway Management Policies following Midface Surgery in Syndromic Craniosynostosis.

Plastic and reconstructive surgery
2024

Early diagnostic clues of mucolipidosis type II: Significance of radiological findings.

American journal of medical genetics. Part A
2023

Children with Rare Nager Syndrome-Literature Review, Clinical and Physiotherapeutic Management.

Genes
2024

Prenatal Diagnosis of Fetal Micrognathia at 11-20 Weeks of Gestation: A Prospective Observation Study.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
2024

A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency.

Molecular genetics and metabolism
2024

Long-Term Follow-up of Untreated Adult Patients with Spondylothoracic Dysostosis (Jarcho-Levin Syndrome).

The Journal of bone and joint surgery. American volume
2024

Incomplete spinal cord injury following minor trauma in two siblings with spondylocostal dysostis type 6.

Spine deformity
2024

Jarcho-Levin syndrome with diastematomyelia and a dorsal dermal sinus.

Radiology case reports
2023

First and second branchial arch involvement in mandibulofacial dysostosis Guion-Almeida type.

European journal of paediatric dentistry
2023

Crouzon's syndrome and its dentofacial features.

BMJ case reports
2024

The importance of skeletal x-ray screening for dysostosis multiplex in the early diagnosis of mucopolysaccharidosis.

Clinical imaging
2024

LeFort III Versus Monobloc Frontofacial Advancement: A Comparative Analysis of Soft Tissue Changes.

The Journal of craniofacial surgery
2023

Plea for systematic prenatal genes panel testing when facing isolated craniosynostosis on fetal imaging.

European journal of obstetrics, gynecology, and reproductive biology
2023

The clinical and genotypic-phenotypic findings of mucopolysaccharidosis VI patients: an Iraqi single-study descriptive study.

Annals of medicine and surgery (2012)
2023

Short stature, dysostosis multiplex and storage disorder: mucolipidosis II.

BMJ case reports
2023

Case report: Exome sequencing revealed disease-causing variants in a patient with spondylospinal thoracic dysostosis.

Frontiers in pediatrics
2023

Identification of two novel MYH3 variants causing different phenotypes in prenatal diagnosis.

Prenatal diagnosis
2023

Cleidocranial Dysplasia: A Rare Case Report.

Journal of pharmacy &amp; bioallied sciences
2023

A novel homozygous HES7 splicing variant causing spondylocostal dysostosis 4: a case report.

Frontiers in pediatrics
2023

AI-based diagnosis in mandibulofacial dysostosis with microcephaly using external ear shapes.

Frontiers in pediatrics
2023

Clinical and molecular study of Egyptian patients with Treacher Collins syndrome.

Clinical dysmorphology
2024

Severity of Mandibular Dysmorphology in Treacher Collins Syndrome for Stratification of Perioperative Airway Risk.

The Journal of craniofacial surgery
2023

[TCOF1 Gene variation in Treacher Collins syndrome and evaluation of speech rehabilitation after bone bridge surgery].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2023

EVC-EVC2 complex stability and ciliary targeting are regulated by modification with ubiquitin and SUMO.

Frontiers in cell and developmental biology
2023

Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations.

Frontiers in pediatrics
2023

Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review.

Acta neurologica Belgica
2024

Mandibular Dysmorphology and Clinical Presentation in Treacher Collins Syndrome.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2023

Functional Characterization of Novel Lunatic Fringe Variants in Spondylocostal Dysostosis Type-III with Scoliosis.

Human mutation
2023

Obstructive Sleep Apnea in Adults with Treacher Collins Syndrome is Related with Altered Anthropometric Measurements, Increased Blood Pressure and Impaired Quality of Life.

Sleep science (Sao Paulo, Brazil)
2024

Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2023

A recurrent homozygous LMNA missense variant p.Thr528Met causes atypical progeroid syndrome characterized by mandibuloacral dysostosis, severe muscular dystrophy, and skeletal deformities.

American journal of medical genetics. Part A
2023

[Acquired form of Chiari 1.5 malformation in Crouzon syndrome (dysostosis craniofacialis)].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
2023

An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome.

Pediatric hematology and oncology
2023

Identification of a Novel Nonsense Variant in the DLL3 Gene Underlying Spondylocostal Dysostosis in a Consanguineous Pakistani Family.

Molecular syndromology
2023

Apert Syndrome: Selection Rationale for Midface Advancement Technique.

Advances and technical standards in neurosurgery
2023

Long-term follow-up of a patient diagnosed with Crouzon syndrome who underwent Le Fort I and III distraction osteogenesis using a rigid external distractor system.

The Angle orthodontist
2023

Prenatal diagnosis of Treacher Collins syndrome: A case report and literature review.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2023

Use of adipose derived stem cells in Treacher Collins syndrome.

European review for medical and pharmacological sciences
2023

Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population.

Molecular genetics &amp; genomic medicine
2023

POLR1A variants underlie phenotypic heterogeneity in craniofacial, neural, and cardiac anomalies.

American journal of human genetics
2023

Skeletal Dysplasia Families: A Stepwise Approach to Diagnosis.

Radiographics : a review publication of the Radiological Society of North America, Inc
2023

GM1 gangliosidosis: patients with different phenotypic features and novel mutations.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Identification of bi-allelic LFNG variants in three patients and further clinical and molecular refinement of spondylocostal dysostosis 3.

Clinical genetics
2023

Hospitalizations from Birth to 28 Years in a Population Cohort of Individuals Born with Five Rare Craniofacial Anomalies in Western Australia.

The Journal of pediatrics
2023

Clinical heterogeneity of NADSYN1-associated VCRL syndrome.

Clinical genetics
2023

Molecular Scalpels: The Future of Pediatric Craniofacial Surgery?

Plastic and reconstructive surgery
2023

Esophageal Atresia With or Without Tracheoesophageal Fistula: Comorbidities, Genetic Evaluations, and Neonatal Outcomes.

Cureus
2025

Bonebridge Implantation in Treacher-Collins Syndrome With Conductive Hearing Loss-Case Report.

Ear, nose, &amp; throat journal
2023

Posterior Calvarial Augmentation for Syndromic Multi-Sutural Craniosynostosis: Crouzon Syndrome.

Neurology India
Ver todos os 1.608 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Disostose.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Disostose

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The Diagnostic Odyssey of a Biochemically Confirmed Case of ML II: The First Western Patient With LYSET Deficiency.
    Clinical genetics· 2026· PMID 41858182mais citado
  2. Genetic and Molecular Characterization of Treacher Collins Syndrome in Three Mexican Families.
    International journal of molecular sciences· 2026· PMID 41752027mais citado
  3. The Phenotypic Spectrum of Miller Syndrome: Insight From a French Cohort.
    Clinical genetics· 2026· PMID 41339098mais citado
  4. Evaluation of a Facial Dysmorphology Analysis Algorithm (Face2Gene) in Identifying Treacher Collins Syndrome Amongst Diverse Population.
    Orthodontics &amp; craniofacial research· 2026· PMID 41817050mais citado
  5. Lamb-Shaffer syndrome in a Chinese adolescent: A case report.
    Medicine· 2026· PMID 41790631mais citado
  6. Fucosidosis.
    · 1993· PMID 41926607recente
  7. Prenatal Ultrasound and Genetic Diagnosis of EFTUD2 Haploinsufficiency in Two Fetuses: A Case Series.
    Appl Clin Genet· 2026· PMID 41923825recente
  8. [Genetic analysis of a de novo EFTUD2 variant causing Mandibulofacial dysostosis with microcephaly in a fetus].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi· 2026· PMID 41918385recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:364559(Orphanet)
  2. MONDO:0018234(MONDO)
  3. GARD:21571(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q1269307(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Disostose
Compêndio · Raras BR

Disostose

ORPHA:364559 · MONDO:0018234
Ensaios
3 ativos
Medicamentos
7 registrados
MedGen
UMLS
C0013393
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades